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ABSTRACT 
Prematurity is a global health problem, affecting about 11% of infants born 
worldwide. Due to the recent advancements in neonatal medicine the rates of 
preterm births are increasing and especially the survival of very and extremely 
preterm. Preterm born infants are at high risk for neurodevelopmental deficits, which 
have a lifelong impact. Therefore it is of utmost clinical importance to find a screening 
tool to detect infants at high risk that can possibly benefit from early intervention 
programs.  
In the present work we aim at investigating neuronal biomarkers in preterm and term 
born infants in order to examine their ability to predict neurodevelopmental outcome. 
Behavioral tests alone are inadequate to assess cognition in early infancy and 
therefore neuronal biomarkers are considered. Two methods are explored: an 
electrophysiological approach, using auditory event related potentials (AERPs) and a 
protein of neuroaxonal injury found in the blood named neurofilament (Nf). Three 
publications are included. First a systematic review of the literature, examining the 
association between AERPs and cognitive outcome in preterm born infants. This 
review is followed by a pilot study, where neonatal AERPs are investigated and 
correlated with neurodevelopmental outcome at 2 years in healthy very preterm and 
term born infants. In particular discrimination and habituation are examined as early 
forms of attention and learning respectively. Finally, we investigated a promising 
biomarker of neuroaxonal injury Nf light chain (NfL) for the very first time in preterm 
and term born infants during the first week of life.  
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I. INTRODUCTION 
1.1. Prematurity and neurodevelopmental outcome 
Preterm birth is defined as delivery before 37 completed weeks of gestation (WHO, 
2018). The prevalence of preterm birth is about 11% worldwide, with higher incidence 
in Africa and South Asia (Blencowe et al., 2012). Prematurity is the main cause of 
infant death (Liu et al., 2015) and surviving preterm born infants are at higher risk for 
neurodevelopmental deficits as compared to infants born at term (Bhutta, Cleves, 
Casey, Cradock, & Anand, 2002). Based on the gestational age (GA), preterm infants 
are classified as follows: moderate to late preterm (32-36 weeks GA), very preterm 
(29-31 weeks GA) and extremely preterm (below 28 weeks GA) (WHO, 2018). The 
risk of cognitive impairments due to preterm birth increases exponentially with the 
degree of prematurity at birth (Larroque et al., 2008). It is estimated that 52% of 
extremely preterm infants, 24% of very preterm infants and 5% of moderate to late 
preterm infants suffer from neurodevelopmental impairments (Blencowe et al., 2012). 
Cognitive impairments include a decrement in IQ points, attention and language 
problems as well as deficits in executive functions (i.e. inhibition, planning, cognitive 
flexibility, working memory and verbal fluency) (Aarnoudse-Moens, Weisglas-
Kuperus, van Goudoever, & Oosterlaan, 2009; Johnson & Marlow, 2017; Ribeiro et 
al., 2011). Socio-behavioral sequelae are also common and preterm infants are at 
higher risk for autism and hyperactivity disorders (Johnson & Marlow, 2017; Moreira, 
Magalhaes, & Alves, 2014). These deficits may persist into adulthood and therefore 
influence later academic and professional achievements of former preterm children 
(Johnson & Marlow, 2017). Besides cognitive and behavioral deficits associated with 
prematurity, motor impairments are also common (Moreira et al., 2014), but exceed 
the scope of the current work.  
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With increasing medical knowledge and expertise, the survival rate of preterm and 
especially very and extremely preterm born infants rises dramatically (Blencowe et 
al., 2013). With a global total of 15 million preterm infants born in 2010 (Blencowe et 
al., 2012), the worldwide burden of this incidence and accompanying complications 
should not be underestimated. It is unclear whether increasing neonatal medicine 
improvements lead to a decrease in later neurodevelopmental deficits (Allotey et al., 
2018; Johnson & Marlow, 2017). Hence there is a need for cognitive assessment 
tools to identify those preterm born infants at higher risk for later deficits. A reliable 
method to assess neonates at risk would allow allocation to early intervention 
programs. Intervention programs focusing on developmental care, parenting, 
environmental and behavioral factors are found to be effective (Spittle, Orton, 
Anderson, Boyd, & Doyle, 2015; Van Hus et al., 2013; Verkerk et al., 2012). Given 
the neuroplasticity in infants, it is important to offer such programs as early as 
possible during and after discharge from the neonatal intensive care unit (NICU). 
However due to the economic costs of these programs, it is not feasible to provide 
this preventive intervention to all premature infants, especially in low-income 
countries. 
Objective methods to detect neonates at higher risk are currently lacking (Streri, de 
Hevia, Izard, & Coubart, 2013; Thierry, 2005; Ullman et al., 2015) and behavioral 
tests are not reliable to assess cognitive functioning in neonates (Picton & Taylor, 
2007; Wickremasinghe et al., 2012). In the next sections we investigate 
neuroimaging tools as well as blood biomarkers in order to evaluate its efficacy to 
detect preterm infants with a high-risk profile for developmental disorders.  
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1.2. Neuroimaging as screening and prediction tool  
Neuroimaging techniques such as cranial ultrasound (CUS) and structural magnetic 
resonance imaging (MRI) are routinely used in clinical settings to detect brain 
abnormalities as well as predict neurodevelopmental outcome (Rademaker et al., 
2005). CUS is a non-invasive, simply feasible and highly effective bedside tool to 
serially evaluate the preterm brain. Using this tool common brain conditions 
associated with prematurity, such as hemorrhages or white matter damage, can be 
detected (Plaisier et al., 2015). Most common complications are periventricular 
leukomalacia (PVL) and intraventricular hemorrhage (IVH) (Ortinau & Neil, 2015; 
Volpe, 2009a). CUS is also found to be an effective prediction tool for cognitive 
outcome. In particular ventricomegaly at term equivalent age was associated with a 
worse cognitive outcome at 2 years corrected age in very preterm infants (Brouwer et 
al., 2014), as well as severe IVH or intraparenchymal hemorrhages shown on an 
early CUS (Franckx, Hasaerts, Huysentruyt, & Cools, 2018).   
For a more detailed screening of preterm brain injury, such as cerebellar 
malformations or more subtle white and grey matter abnormalities, a CUS is unable 
to provide adequate information (Plaisier et al., 2015). MRI has a higher spatial 
resolution and is therefore more precise to detect brain lesions. This comes at a cost 
of being more invasive, not applicable in bedside testing and less affordable. 
However prospective studies in preterm infants have found several indications of 
unfavorable outcome either using structural or functional MRI. Larger ventricular 
volumes are associated with an adverse neurodevelopmental outcome until early 
school age (Keunen et al., 2016). Also moderate to severe white matter abnormality 
and the presence of cerebellar lesions as detected by MRI are related to lower 
cognitive outcomes scores (Anderson, Cheong, & Thompson, 2015; Hintz et al., 
2015). Even though brain damage has serious implications on outcome, preterm 
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infants without CUS/MRI documented lesions still present neurodevelopmental 
impairments (Lemola et al., 2017). The underlying neurologic injury due to preterm 
birth has been described as “encephalopathy of prematurity” (Ortinau & Neil, 2015; 
Volpe, 2009b). From functional MRI (fMRI) studies, different patterns of brain activity 
are observed between preterm and term born infants during the neonatal period 
(Baldoli et al., 2015) and persisting in adulthood (White et al., 2014). Moreover 
associations between fMRI paradigms and cognitive outcome tests are found (He et 
al., 2018; Ullman et al., 2015). 
In contrast to MRI, electroencephalography (EEG) has a high temporal resolution and 
allows to investigate brain functioning in a non-invasive manner (Mantini, Marzetti, 
Corbetta, Romani, & Del Gratta, 2010). EEG can be passively administered in 
neonates in a bedside setting. To monitor neonatal brain activity at the NICU 
amplitude-integrated EEG (aEEG) is frequently used. aEEG has also proven to be 
effective as predictor of neurodevelopmental outcome (Wikstrom et al., 2012). In 
order to evaluate cognitive functioning more precisely and in a time-efficient manner, 
event-related potentials (ERPs) are considered suitable (Picton & Taylor, 2007). 
ERPs are characterized by positive and negative amplitude peaks following 
stimulation and give very precise information about the timing of cognitive processes 
(Key, Dove, & Maguire, 2005). In particular oddball paradigms are used as 
stimulation paradigms, since they are a simple and effective cognitive discrimination 
task to test early cognitive functions (Ceponiene et al., 2002; Zhang, Li, Zheng, 
Dong, & Tu, 2017). The stimuli used in an oddball paradigm exist in several 
modalities (i.e. visual, tactile, somatosensory, etc.), but in language studies the 
auditory modality is used. The auditory oddball paradigm consists of presenting 
repetitive “standard” stimuli (i.e. tones, phonemes or syllables) sporadically 
interrupted by “deviant” stimuli. Several auditory ERP (AERP) components have 
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been investigated as possible predictors of cognitive outcome. Common AERPs are 
P1, N2, P3, MMN, N400 and reflect different cognitive processes: auditory inhibition, 
stimulus discrimination, memory updating and response preparation, preattentive 
sensory memory and sematic processing respectively (Key et al., 2005). Some AERP 
components in children are found to be predictive of neurodevelopmental outcome 
(Hovel et al., 2015; Korpilahti, Valkama, & Jansson-Verkasalo, 2016). 	
 
A combination of structural and functional neuroimaging tools, in particular MRI and 
ERPs, seem to provide the best neuronal biomarkers for detection of brain injuries 
and for prediction of neurodevelopmental outcome. Using both techniques one 
avoids the trade-off between spatial and temporal information (Jorge, van der Zwaag, 
& Figueiredo, 2014; Mantini et al., 2010). Although very precise, it can be time 
consuming and costly to perform in each preterm born infant at the NICU and 
normative standards are challenging to create. These parameters need to be taken 
into account when selecting biomarkers used to discriminate between patients at 
high and low risk and select those eligible for intervention programs.  
1.3. Blood biomarkers as screening and prediction tool  
Whereas neuroimaging tools provide us with an objective assessment of brain 
injuries and cognitive functioning, it can be challenging to perform in all preterm born 
infants. Moreover neuroimaging techniques are still indirect measurements and not 
every NICU owns these facilities. Blood biomarkers on the other hand offer a rapid 
indication of injury as seen in increased levels (Disanto et al., 2017; Michetti et al., 
2012). Blood punctures are routinely taken at the NICU, which makes it less 
complicated and less invasive to analyze an additional neuronal biomarker.  
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Especially in neurodegenerative diseases blood biomarkers have been investigated 
in order to improve early diagnostics, monitor disease progression and assess 
efficacy of new drugs. A promising biomarker of neuraxonal injury, neurofilament (Nf), 
has been found very valuable in acute and chronic neuronal damage in adults. Nf 
consists of several subunits and is released into the cerebrospinal fluid and 
eventually the peripheral blood in case of neuronal injury (Petzold, 2005). 
Cerebrovascular accident, traumatic brain injury, dementia and multiple sclerosis are 
examples where Nf levels are dramatically increased as compared to healthy controls 
(Barro et al., 2018; De Marchis et al., 2018; Mattsson, Andreasson, Zetterberg, 
Blennow, & Alzheimer's Disease Neuroimaging, 2017; Rohrer et al., 2016; Shahim, 
Zetterberg, Tegner, & Blennow, 2017). Moreover Nf is found to be associated with 
MRI markers of disease severity and can be administered as indicator of disease 
progression (Kuhle et al., 2016). Other studies confirmed the correlation between Nf 
and imaging measurements of the injury (Barro et al., 2018; Gattringer et al., 2017). 
Furthermore Nf was found to be predictive of neurological outcome (Rana et al., 
2013; Shahim et al., 2016).  
Data on Nf are sparse in neonates, but some studies point out the promising use in 
infants. As shown by a study in children with febrile seizures, prolonged febrile 
seizures led to raised serum Nf heavy chain (NfH) (Matsushige et al., 2012). Similarly 
serum NfH was increased in neonates with hypoxic-ischemic encephalopathy (HIE) 
compared to healthy neonates (Douglas-Escobar et al., 2010; Toorell, Zetterberg, 
Blennow, Savman, & Hagberg, 2018). A more recent study (Shah et al., 2018) found 
NF light chain (NfL) predictable of MRI outcome, in particular higher NfL levels were 
observed in case of unfavorable MRI outcome. Taken together, the potential use of 
this biomarker might also be extended to the preterm population.  
 12 
1.4. Research objectives 
The present PhD thesis aims at investigating neuronal biomarkers in preterm born 
infants in order to discriminate infants at higher risk for neurodevelopmental deficits. 
Given the advances in neonatal medicine, there is an increasing worldwide incidence 
of preterm births and a rising survival rate of extremely preterm born infants. 
Therefore it is of utmost clinical importance to find a screening tool to detect infants 
that might benefit from early intervention programs. In this thesis two neuronal 
biomarker methods are explored: an electrophysiology approach using AERPs and a 
neuronal scaffolding protein, Nf.  
First a systematic review of the literature was performed about the predictive capacity 
of AERPs in preterm born infants, in other words investigating the association 
between AERPs and cognitive outcome. This review is followed by a pilot study, 
where neonatal AERPs are investigated and correlated with neurodevelopmental 
outcome at 2 years in healthy very preterm and term born infants. In particular 
discrimination and habituation are examined as early forms of attention and learning 
respectively. Finally, we investigated a promising biomarker of neuroaxonal injury NfL 
in preterm and term infants during the first week of life.  
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A B S T R A C T
Prematurity is a known risk factor for later cognitive deﬁcits. At present there are neither behavioral nor neu-
rological tests available to detect those preterm infants who would beneﬁt most from early interventions.
Neurophysiologic methods, and more speciﬁcally, auditory event-related potentials (AERPs) are convenient
tools to investigate early cognitive functioning. However, the capability of AERPs as a prognostic factor for
mental development in preterm infants remains unclear. The present systematic search of the literature yielded
1016 articles, out of which 13 were included. Both prospective and cross-sectional studies reported a relationship
between AERPs and cognitive outcome. Our results show that larger amplitudes and shorter latencies of late
AERPs are related to better cognitive outcomes. Additional studies are needed to corroborate our ﬁndings re-
garding this potential use of AERPs in the individual evaluation of preterm born infants.
1. Introduction
Preterm birth is deﬁned by the WHO as birth before 37 completed
weeks of gestation (WHO, 2016). Children born preterm are at sig-
niﬁcant risk for impaired cognitive development (Bhutta et al., 2002;
Luu et al., 2011). It is estimated that 52% of children born before 28
weeks of gestation, 24% of children born at 28–31 weeks, and 5% of
children born at 32–36 weeks suﬀer from neurodevelopmental im-
pairments (Blencowe et al., 2012), including cognitive and behavioral
issues, which may persist into adulthood (Johnson and Marlow, 2017).
With a global total of 15 million babies born preterm in 2010, the
burden of these impairments should not be underestimated (Blencowe
et al., 2012).
While there is evidence that early intervention can signiﬁcantly
improve cognitive development in preterm born children and adoles-
cents (Spittle et al., 2015), there is no reliable cognitive assessment tool
to identify newborns in need of early intervention (Lobo and Galloway,
2013). Bearing in mind the importance of brain plasticity for early
development, a timely start of targeted interventions is of utmost im-
portance (Wass, 2015).
Over the past few years, an increasing amount of research has fo-
cused on the detection of diﬀerences in neonatal brain activity between
infants born preterm and those born at term using various neuroima-
ging techniques (Mento and Bisiacchi, 2012). The apparent preference
of functional neuroimaging techniques over behavioral assessments in
infants born preterm is the possibility to objectively administer these
tests as early as the neonatal period, when early forms of cognitive skills
are already present (Streri et al., 2013). In particular, the use of elec-
troencepahlography (EEG) allows for a non-invasive, time-eﬃcient
bedside evaluation of neonatal brain activity with a high temporal re-
solution (Kamel and Malik, 2015). A few research groups investigated
whether neurophysiologic techniques such as EEG, amplitude-in-
tegrated EEG and auditory event-related potentials (AERPs) could be
used to detect or predict cognitive impairments in preterm born chil-
dren (deRegnier, 2005, 2008; Fogtmann et al., 2017).
The objective of this systematic review is to investigate whether
deﬁned AERP peaks can be used as a marker for cognitive and language
functioning in children born preterm. Both cohort studies and cross-
sectional studies will be considered. Implications for clinical practice
and future research are discussed. This is, to our knowledge, the ﬁrst
systematic review to summarize the evidence of AERPs used to assess
and predict cognitive functioning in children born preterm.
https://doi.org/10.1016/j.neubiorev.2018.02.011
Received 22 August 2017; Received in revised form 5 February 2018; Accepted 13 February 2018
⁎ Corresponding author at: University Children’s Hospital Basel, Division of Neuropediatrics and Developmental Medicine, Spitalstrasse 33, 4031 Basel, Switzerland.
1 Shared ﬁrst authorship.
E-mail address: antoinette.depoorter@ukbb.ch (A. Depoorter).
Abbreviations: EEG, electroencephalography; AERP, auditory event-related potential; GA, gestational age; MMN, mismatch negativity; BSID, Bayley Scales of Infant Development;
WPPSI, Wechsler Preschool and Primary Scale of Intelligence; BNT, Boston Naming Test; NEPSY, Developmental NEuroPSYchological Assessment; CDI, MacArthur Communicative
Development Inventory; DAYC, Developmental Assessment of Young Children
Neuroscience and Biobehavioral Reviews 89 (2018) 99–110
Available online 17 February 2018
0149-7634/ © 2018 Elsevier Ltd. All rights reserved.
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2. Methods
2.1. Search strategy
This review is written in accordance with the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines
(Moher et al., 2009). We did not use a review protocol. A.D. and J.F.
carried out a systematic search of the databases Pubmed, Embase, and
PsycINFO between May 1st and May 31st, 2017. Records published
between 01.01.1990 and 31.05.2017 were screened for studies whose
title or abstract indicated relevance to our research questions. In ad-
dition, we searched reference lists of published reviews for eligible
studies.
A detailed description of the search strategy is given in the
Appendix A.
2.2. Eligibility criteria
Articles were selected according to the following inclusion criteria:
1. Cross-sectional, prospective, or retrospective original research papers
investigating the relation between AERPs and cognitive outcome in
children born preterm (<37 weeks of gestation); 2. The study in-
vestigated long latency event-related potentials including N1, P2, P300,
Mismatch Negativity (MMN), and Contingent Negative Variation; 3.
Subjects were no older than 18 years at the time of study participation;
4. Studies were published in one of the following languages: English,
French, German, Italian, or Dutch. We excluded studies if only an ab-
stract or conference paper was published at the time of our search, in
the absence of a full-text scientiﬁc article. In case of uncertainty, A.D.
and J.F. consulted with P.W. to discuss the studies in question until
agreement was reached.
2.3. Data extraction
From the included studies, we extracted data on study design,
number of subjects, subject characteristics, EEG methodology, AERP
peaks investigated, type of neuropsychological testing, as well as sta-
tistical correlations between AERPs and outcome. Only signiﬁcant
(p < .05) correlations between AERPs and cognitive outcome are
presented. A number of studies investigated not only the correlation
between AERPs and cognitive outcome, but also the diﬀerences in
AERPs between infants born preterm and at term, as well as technical
questions regarding the administration of AERPs. Since these data do
not directly pertain our research question, we did not report them in
this review. Similarly, if a study comprised of a group of preterm
children as well as a term-born control group, information is given only
on characteristics of participants born preterm. No standardized data
extraction tool was used.
2.4. Quality assessment
The included studies were assessed for their methodology by A.D.
and J.F. using an adapted version of the Quality in Prognostic Studies
(QUIPS) Checklist (Hayden et al., 2013), which grades studies re-
garding study participation, study attrition, prognostic factor mea-
surement, outcome measurement, study confounding, and statistical
analysis and reporting. We divided each of these six categories into
three items. Studies received a score from 0 to 3 depending on how
many items they fulﬁlled, with a score of 0 reﬂecting the poorest and a
score of 3 reﬂecting the highest methodological quality. Studies which
do not contain a 0 in any category are considered of good overall
quality. The attrition category was scored as “N/A” (not applicable) in
cross-sectional studies. The studies also received a grade from I to V
(strongest to weakest) for their study design according to the The
American Society of Plastic Surgeons Evidence Rating Scale (The ASPS
Evidence Rating Scales, n.d.) adapted from the 2011 Oxford CEBM
Levels of Evidence (OCEBM Levels of Evidence Working Group).
Our adapted version of the QUIPS Checklist can be found in the
Appendix A and the study-by-study quality assessment in Table 1.
3. Results
3.1. Identiﬁed studies
The electronic literature search led to the identiﬁcation of 1016
articles in total, of which 167 full-text articles were screened for elig-
ibility after excluding 849 non-relevant studies based on the title and
abstract. Out of the full-text articles, 146 studies were eliminated: We
excluded 79 duplicates, 67 studies which did not investigate the rela-
tion between AERPs and cognition in preterm infants, two studies
which used outdated AERP nomenclature, and six conference papers
which did not provide enough data to compare them to full-text arti-
cles. 13 studies met the inclusion criteria for the qualitative synthesis.
No additional articles were identiﬁed through hand search of reference
lists. A ﬂowchart of the search and selection process is shown in Fig. 1.
3.2. Study characteristics
The 13 included studies investigating the relationship between
AERPs and cognitive outcome were published between 2003 and 2016.
Table 1
Quality assessment of included studies using an adapted QUIPS checklist.
Study Participation Attrition Prognostic Factor
Measurement
Outcome
Measurement
Confounding Statistical Analysis and
reporting
Overall
Score
Quality
Rating
Weber et al. (2016) 3 +++ 2 ++- 3 +++ 3 +++ 1 –+ 2 +-+ 14 II
Korpilahti et al. (2016) 2 -++ N/A 3 +++ 3 +++ 2 ++- 3 +++ 13 IV
Hovel et al. (2015) 3 +++ N/A 3 +++ 3 +++ 3 +++ 2 ++- 14 IV
Paquette et al. (2015) 3 +++ N/A 3 +++ 2 +-+ 3 +++ 3 +++ 14 IV
Maitre et al. (2014) 3 +++ 0 — 2 -++ 2 -++ 2 +-+ 2 -++ 11 II
Maitre et al. (2013) 3 +++ 1 –+ 2 -++ 2 -++ 1 –+ 3 +++ 12 II
Leipala et al. (2011) 2 ++- 1 -+- 2 -++ 1 -+- 0 — 2 ++- 8 II
Jansson-Verkasalo et al.
(2010)
0 — 1 +– 3 +++ 3 +++ 0 — 3 +++ 8 II
Mikkola et al. (2010) 2 ++- N/A 2 ++- 3 +++ 0 — 1 –+ 8 IV
Mikkola et al. (2007) 2 ++- N/A 3 +++ 3 +++ 0 — 3 +++ 11 IV
Fellman et al. (2004) 3 +++ 2 ++- 2 ++- 1 –+ 0 — 2 -++ 10 II
Jansson-Verkasalo et al.
(2004)
2 -++ 1 +– 3 +++ 3 +++ 1 –+ 0 — 10 II
Jansson-Verkasalo et al.
(2003)
2 -++ 1 +– 3 +++ 3 +++ 0 — 3 +++ 11 IV
+=criteria fulﬁlled, -=criteria not fulﬁlled, N/A=not applicable, II = prospective cohort study, IV= cross-sectional study.
A. Depoorter et al. Neuroscience and Biobehavioral Reviews 89 (2018) 99–110
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Out of those 13 studies, seven were prospective cohort studies (Fellman
et al., 2004; Jansson-Verkasalo et al., 2003, 2004, 2010; Leipala et al.,
2011; Maitre et al., 2013, 2014; Paquette et al., 2015; Weber et al.,
2016) and six were cross-sectional studies (Hovel et al., 2015; Jansson-
Verkasalo et al., 2003; Korpilahti et al., 2016; Mikkola et al., 2007,
2010; Paquette et al., 2015). One of these studies (Jansson-Verkasalo
et al., 2003) was part of a prospective follow-up, however the ﬁndings
in which we are interested were taken at one point in time and there-
fore it was treated as a cross-sectional study. The studies were con-
ducted by only six research groups. Speciﬁcally, we included several
papers published by three research groups from the following study
sites: Oulu University Hospital, Helsinki University Central Hospital,
and Vanderbilt University Medical Center.
Looking at the study participants, 12 studies included both preterm
and term born infants, with 10 studies dividing participants into a
preterm group and a term born control group (Fellman et al., 2004;
Jansson-Verkasalo et al., 2003, 2004, 2010; Korpilahti et al., 2016;
Leipala et al., 2011; Mikkola et al., 2007, 2010; Paquette et al., 2015;
Weber et al., 2016) and two studies including one large cohort con-
sisting of both preterm and term born infants (Maitre et al., 2013,
2014). One study (Hovel et al., 2015) exclusively evaluated preterm
born infants. Overall, the gestational age (GA) of the prematurely born
participants was 22–37 weeks. The age at assessment ranged from<38
weeks to 9 years and at follow-up from 6 months to 6 years. Two studies
(Maitre et al., 2013, 2014) conducted AERP measurements before the
corrected term age of 40 weeks, if participants were clinically stable.
Five out of the seven prospective studies (Fellman et al., 2004; Leipala
et al., 2011; Maitre et al., 2013, 2014; Weber et al., 2016) assessed
AERPs at neonatal age, while one study group which performed several
prospective studies measured AERPs at a later age. Eight studies (Hovel
et al., 2015; Jansson-Verkasalo et al., 2003, 2004; Korpilahti et al.,
2016; Leipala et al., 2011; Maitre et al., 2013, 2014; Mikkola et al.,
2007) included subjects with severe brain damage, such as intracranial
hemorrhage grade III or IV or cerebral palsy, while three studies
(Fellman et al., 2004; Paquette et al., 2015; Weber et al., 2016) only
included individuals with no major brain abnormalities. From two
studies (Jansson-Verkasalo et al., 2010; Mikkola et al., 2010) it was not
possible to extract information on participants’ clinical diagnoses. The
two studies (Maitre et al., 2013, 2014) which followed the mixed cohort
of preterm and term born children recruited participants who were
hospitalized at the NICU, without mentioning the reason for their NICU
admission. Also, no age range or number of children born preterm was
given.
The included studies used diﬀerent auditory stimulation paradigms
to investigate the AERPs. Five studies (Fellman et al., 2004; Hovel et al.,
2015; Leipala et al., 2011; Mikkola et al., 2007; Weber et al., 2016)
presented tones in an oddball paradigm. Four out of these ﬁve studies
used syllables (Jansson-Verkasalo et al., 2003, 2004, 2010; Paquette
et al., 2015) and one study (Mikkola et al., 2010) used animal sounds.
Two studies randomly presented syllables (Maitre et al., 2013, 2014)
and one study (Korpilahti et al., 2016) used words and pseudowords as
stimuli in a pseudo-random order. The authors also used diﬀerent AERP
nomenclatures to describe the investigated peaks, but all were long
latency AERPs and therefore endogenous (Sur and Sinha, 2009).
Diﬀerent standardized tests were used to assess the neurodevelop-
mental outcome across the studies: The Bayley Scales of Infant
Development (BSID), Boston Naming Test (BNT), Developmental
NEuroPSYchological Assessment (NEPSY), Wechsler Preschool and
Primary Scale of Intelligence (WPPSI), MacArthur Communicative
Development Inventory (CDI) and Developmental Assessment of Young
Children (DAYC).
The study characteristics are visualized in Table 2.
Fig. 1. Search ﬂowchart.
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Table 3
Relation between AERPs and neurodevelopmental outcome.
Authors, year of
publication
Statistical analysis Statistical results Main ﬁndings
Weber et al. (2016) Pearson correlation dMMN at Cz and correlated positively with MDI (r= 0.65**)
and PDI (r= 0.48*).
Larger diﬀerence in MMN between the ﬁrst and third
stimulation block correlated with better MDI and PDI
scores.
Words:
Korpilahti et al.
(2016)
Pearson correlation - Auditory attention correlated negatively with N200 A at
right (r=−0.41*), left (r=−0.47**), midline
(r=−0.47**), frontal (r=−0.46*), central
(r=−0.54**), parietal (r=−0.45*) electrodes.
- Pseudoword repetition correlated negatively with N200 A
at frontal (r=−0.42*) electrodes.
Larger N200 amplitude correlated with better auditory
attention and pseudoword repetition (term and preterm
subjects combined).
Pseudowords:
- Auditory attention correlated negatively with N200 A at
parietal (r=−0.38*) electrodes.
- Pseudoword repetition correlated negatively with N200 A
at right (r=−0.39*), left (r=−0.39*), frontal
(r=−0.43*) electrodes.
Hovel et al. (2015) Pearson correlation and
linear or binary logistic
regression analysis
P1 (r= 0.25*) and N2 (r= 0.32**) L correlated positively with
VAt.
Shorter P1 and N2 latencies correlated with faster visual
attention. More positive mean amplitudes 150-450ms post
stimulus onset correlated with better cognitive test results.
Duration deviant:
- 150–200ms MA: positive correlation with PP (r= 0.27*)
- 200–250ms MA: positive correlation with PP (β=0.26*)
- 300–350ms MA: positive correlation with IVQ
(r=0.23***), PIQ (r= 0.20***), PSQ (r=0.36**), FSIQ
(r=0.26*), VAco (r= 0.22***), PP (r= 0.21***) and SR
(r=0.25*)
- 350–400ms MA: positive correlation with PIQ
(β=0.21***), PSQ (β=0.35**) and VAco (β=0.34**)
- 400–450ms MA: positive correlation with PSQ
(β=0.27*), VAco (β=0.24***) and negative correlation
with VAt (β=−0.25***)
Direction deviant:
- 150–200ms MA: positive correlation with VAt (r= 0.25*)
- 250–300ms MA: positive correlation with VAt (r= 0.29*)
Paquette et al.
(2015)
Pearson correlation Speech stimuli: Shorter latency of MMN, P150, and N250 correlated with
better expressive and receptive language. Larger P150
amplitude correlated with better expressive language.
Shorter N250 latency correlated with better cognition.
- MMN L correlated negatively with exp. language
(r=−0.39***) and rec. language (r=−0.26*)
- P150 L correlated negatively with exp. language
(r=−0.34**) and rec. language (r=−0.25*)
- P150 A correlated positively with exp. language
(r= 0.23*)
- N250 L correlated negatively with exp. language
(r=−0.34**) and rec. language (r=−0.34**)
Non-speech stimuli:
N250 L correlated negatively with cognition (r=−0.26*)
Maitre et al. (2014) Linear regression At 6 months: Larger hemisphere diﬀerences in ERPs predicted better
communication and cognitive scores at 6 months and to a
smaller extent at 1 year.
- Temporal hemispheric diﬀerences in MA correlated with
DAYC communication scores (coeﬃcient: 1.9*) (adjusted
model)
- Frontal hemispheric diﬀerences in MA correlated with
DAYC cognitive scores (coeﬃcient: −1.9*) (adjusted
model)
At 1 year:
Temporal hemispheric diﬀerences in MA correlated with DAYC
communication scores (coeﬃcient: 2.4*) and cognitive scores
(coeﬃcient: 2.0*) (non-adjusted model.)
Maitre et al. (2013) Ordinary least squares
linear regression model
At 1 year: Larger ERP amplitude signiﬁcantly predicted better
communication and cognitive scores at 1 year as well as
receptive language and cognition at 2 year.Pearson correlation ERP responses contributed 34% to the model predicting
communication and 21% to the model predicting cognitive
scores.
Linear regression At 2 year:
ERP responses contributed 14% for prediction of cognition and
9% for prediction of rec. language
At 1 year:
F3 (/ba/-/ga/ contrast) and communication (r= 0.41*)
At 2 year:
F3 (r= 0.44*), T6 (r= 0.45*) for /du/-/gu/ sound contrast
and cognition
F4 (/ba/-/ga/ contrast)and rec. language (r=−0.51**)
(continued on next page)
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3.3. Methodological quality of included studies
Based on the adapted QUIPS checklist 5 out of the 13 articles were
considered to be of good methodological quality, two of which were
prospective cohort studies (Table 1). Across all studies, the methodo-
logical strengths lay in the prospective factor (e.g. EEG administration)
and outcome measurement (e.g. cognitive testing). The main short-
comings of the included studies were seen in the “attrition” and “con-
founding” categories, with a majority of studies not mentioning or
controlling for important possible confounders.
3.4. Correlations between deﬁned AERPs and neurodevelopmental outcome
The results of the 13 included studies are summarized in the fol-
lowing paragraphs and presented in Table 3. One study (Leipala et al.,
2011) was not considered in the results section, since it did not report
explicitly which correlations the authors performed and what the re-
sults were.
Table 3 (continued)
Authors, year of
publication
Statistical analysis Statistical results Main ﬁndings
Leipala et al. (2011) Pearson correlation No numeric data available 3 out of 72 AERP variables correlated signiﬁcantly with the
2 year outcome.
Jansson-Verkasalo
et al. (2010)
Spearman correlation MMN A correlated positively with the number of produced
words (r2= 0.20*), developed word morphology (r2= 0.27*)
and mean sentence length (r2= 0.38**)
Larger MMN amplitude correlated with fewer produced
words, less developed word morphology, and shorter mean
sentence length.
Mikkola et al.
(2010)
Correlation analysis not
speciﬁed
/ No signiﬁcant correlations were found.
Mikkola et al.
(2007)
Pearson correlation Easy paradigm: Larger P1, N2 and MMN amplitudes correlated with better
verbal IQ and language performance (sentence repetition,
verbal ﬂuency, language domain and phonological
processing).
- Standard P1 correlated with sentence repetition
(r= 0.43*)
- Frequency MMN correlated with verbal IQ (r= 0.43*) and
verbal ﬂuency (r= 0.50*)
- Novel P1 correlated with verbal ﬂuency (r= 0.57*)
Challenging paradigm:
- Frequency N2 correlated with verbal ﬂuency (r= 0.54*)
- Duration P1 correlated with language domain (r= 0.44*)
and phonological processing (r= 0.52*)
All AERP peaks were recorded at Fz and all correlations were
positive.
Fellman et al.
(2004)
Correlation analysis not
speciﬁed
At term: At term:
MDI correlated with parietal P150 A in the 150–250ms time
window (r= 0.60*) and P350 A in the 250–350ms time
window (r= 0.64*) for standard stimuli
Larger P150 and P350 amplitudes correlated with better
MDI scores.
At 6 months: At 6 months:
- MDI correlated with parietal P150 A in the 50–150ms time
window for deviant (r= 0.87**) and standard (r= 0.63*)
stimuli
Larger P150 and N250 amplitudes correlated with better
MDI scores.
- MDI correlated with frontal N250 A in the 250–350ms
time window (r=−0.63*) for standard stimuli
At 1 year:
Larger P3a and N250 amplitudes correlated with better
MDI scores.
At 1 year:
- MDI correlated with frontal N250 A in the 250 350ms time
window (r=−0.59*) for standard stimuli
- MDI correlated with frontal P3a A in the 250–350ms time
window (r= 0.61*) and central P3a A (r= 0.64*) for the
diﬀerence waveform
All correlations were positive.
Jansson-Verkasalo
et al. (2004)
Spearman correlation No numeric data available Individual inspection of ERPs: If MMN absent in
max. 5 out of 9 electrodes, naming ability was normal
(n= 3). If MMN was absent or questionable in 8 or 9
electrodes, naming ability was decreased (n=5).
Jansson-Verkasalo
et al. (2003)
Repeated measures analysis
of variances
MMN amplitude for vowel change signiﬁcantly smaller in
preterms w/ naming diﬃculties than in preterms w/out
naming diﬃculties (F(1,10)= 5.30*) and controls (F
(1,19)= 6.56*).
MMN amplitude signiﬁcantly smaller in preterms w/
naming diﬃculties than in preterms w/out naming
diﬃculties and controls.
MMN amplitude for consonant change signiﬁcantly smaller in
preterms w/ naming diﬃculties than in controls (F
(1,19)= 7.79*)
A= amplitude, L= latency, MA=mean amplitude.
MDI=Mental Developmental Index, PDI=Performance Developmental Index, DAYC=Developmental Assessment of Young Children.
VIQ=Verbal IQ, PIQ=Performance IQ, PSQ=Processing Speed Quotient, FSIQ= Full-Scale IQ, VAco=Visual Attention; number of correct markings, Vat=Visual Attention; time to
complete test, PP=Phonological Processing, SR= Sentence Repetition.
* =p < .05.
** =p < .01.
*** =p < .001.
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The correlations between the AERPs and outcome are described
according to the peak latencies and the results are presented in as-
cending order of age of the study participants.
3.4.1. Long latency auditory event-related potentials
3.4.1.1. First positive peak. This peak was deﬁned as follows by the ﬁve
investigating studies: P150 between 150–250ms (Fellman et al., 2004),
P150 between 50–250ms (Paquette et al., 2015), P1 between
80–180ms (Hovel et al., 2015), P1 between 50–150ms (Mikkola
et al., 2007) and P1 between 90–120ms (Mikkola et al., 2010). Four
of these ﬁve studies found signiﬁcant correlations between either the
amplitude or the latency of the ﬁrst positive peak and
neuropsychological test scores. Fellman et al. (2004) found that the
P150 amplitude at term equivalent age and 6 months correlated
positively with the mental developmental index (MDI) of the BSID at
2 years. Paquette et al. (2015) conducted AERP measurements in
children of three age groups: 3 months, 1 year, and 3 years. For all
ages, larger P150 amplitude and shorter latency correlated with better
BSID language, but not with cognitive scores. In the study by Hovel
et al. (2015), a larger positive amplitude between 150 and 200ms after
stimulus onset correlated with better phonological processing, while
shorter P1 latency correlated with better visual attention in 5 year-old
children. Mikkola et al. (2007), who examined the cohort from the
study by Fellman et al. (2004), found signiﬁcant positive correlations
between the amplitude of P1 and language scores on the NEPSY in
5 year-old children. However, Mikkola et al. (2010) reported that there
were no signiﬁcant correlations between P1 and any of the outcome
measures.
In summary, one prospective study found P150 to be predictive of
later neurodevelopmental outcome, while three cross-sectional studies
reported signiﬁcant correlations between the ﬁrst positive peak and
neurodevelopmental test scores in various age groups. One cross-sec-
tional study with 5 year-old participants yielded no signiﬁcant corre-
lations.
3.4.1.2. First negative peak. This peak was deﬁned as follows by the ﬁve
investigating studies: N250 between 250–350ms (Fellman et al., 2004),
N250 between 150–350ms (Paquette et al., 2015), N2 between
170–330ms (Hovel et al., 2015), N2 between 200–300ms (Mikkola
et al., 2007) and N200 between 200–350ms (Korpilahti et al., 2016).
All studies reported signiﬁcant correlations between this AERP-peak
and outcome tests. Fellman et al. (2004) found that the N250 amplitude
at 6 and 12 months correlated negatively with the MDI of the BSID at
2 years. Paquette et al. (2015) found that the N250 latency correlated
negatively with the BSID language and cognitive scores in children aged
between 3 months and 3 years. Hovel et al. (2015) reported that shorter
N2 latencies are related to faster visual attention in 5 year-old children.
In the study of Mikkola et al. (2007) the N2 amplitude correlated
positively with verbal ﬂuency on the NEPSY in 5 year-old children.
Whereas Korpilahti et al. (2016) found that the larger N200 amplitude,
the better the language and attention subtest scores of the NEPSY in
9 year-old children.
In summary, one prospective study found that a decreased N250
peak is related to a later increased risk for cognitive dysfunction, so did
two cross-sectional studies. Regarding N2/N250 latency two cross-
sectional studies observed that the shorter the latency, the better the
test results.
3.4.1.3. Second positive peak. This peak was deﬁned as follows by the
two investigating studies: P350, P3a between 250–350ms (Fellman
et al., 2004) and P3a between 330–360ms (Mikkola et al., 2010).
Fellman et al. (2004) reported that P350 at term equivalent age as well
as the P3a at 1 year of age correlated positively with the MDI of the
BSID at 2 years. However, Mikkola et al. (2010) did not ﬁnd any
signiﬁcant correlations between P3a and neurodevelopmental outcome
in 5 year-olds.
In summary, P3 was reported to predict cognitive development by
one prospective study, while one cross-sectional study did not report
any signiﬁcant correlations.
3.4.1.4. MMN. The MMN is a negative component elicited in an
auditory oddball paradigm. It peaks around 160–220ms post stimulus
onset and is related to pre-attention and auditory discrimination (Beres,
2017).
Seven studies investigated MMN in relation to the cognitive out-
come. Weber et al. (2016) investigated the MMN by looking at the
diﬀerence in amplitude between the ﬁrst and last stimulation block at
term equivalent age and found that it was predictive of the MDI of the
BSID at 2 years. Jansson-Verkasalo et al. (2010) reported that the MMN
amplitude at 1 year was related to the number of produced words as-
sessed by the CDI at 2 years. One study (Paquette et al., 2015) reported
a negative correlation between the MMN latency and language scores,
but not cognition, on the BSID in children aged between 3 months and 3
years. Two prospective studies of the same cohort (Jansson-Verkasalo
et al., 2003, 2004) found that lower MMN amplitude or the absence of
MMN at 4 years was associated with naming diﬃculties assessed by the
BNT at the age of 4 and 6 years, although they were not statistically
supported. Mikkola et al. (2007) found positive correlations between
the MMN amplitude and verbal intelligence quotient (IQ) and verbal
ﬂuency in 5-year old children. In their other study (Mikkola et al.,
2010) they did not ﬁnd any signiﬁcant correlations between MMN and
attention or executive functioning.
In summary, MMN was the most commonly investigated AERP
component in the included studies, and six studies found it to be pre-
dictive of cognitive outcome. One study did not ﬁnd any relation.
3.4.1.5. N400. Korpilahti et al. (2016) was the only study that
investigated the N400 component, deﬁned as the most negative peak
in the 400–800ms time window.They did not ﬁnd any signiﬁcant
correlations between this peak and behavioral tests in 9-year old
children.
3.4.2. Non-deﬁned peaks
Three studies reported correlations for speciﬁc latency time win-
dows without evaluating deﬁned AERP peaks. The group of Maitre et al.
(2013, 2014) used the same study cohort for two diﬀerent analyses: In
their 2013 study, they calculated the mean amplitude measured 250
until 400ms post stimulus onset. This value at term equivalent age
correlated positively with the communication subscale of the DAYC at
1 year and with cognitive subscales of the BSID at 2 years, but nega-
tively with BSID receptive language scores at 2 years. In a predictive
model the amplitude of AERP diﬀerentiation responses predicted the
communication scores and the cognitive ability at 1 year. At 2 years the
AERP responses predicted cognition and receptive language, while ex-
pressive language contributed less to the predictive model. In their
2014 study, the same cohort was evaluated, but instead of AERP am-
plitudes the hemispheric diﬀerences in AERPs from 250 until 400ms
after stimulus onset were evaluated. The authors found that larger
diﬀerences in AERP amplitudes between the left and right hemisphere
correlated with better DAYC communication and cognitive scores at 6
and 12 months. Even though Hovel et al. (2015) presented correlations
for P1 and N2, they reported correlations for later AERPs in 50ms time
windows. AERP amplitudes between 300 and 450ms after stimulus
onset correlated positively with IQ as measured by the WPPSI as well as
attention and language on the NEPSY in 5 year-olds.
In summary, across three studies, late AERP amplitudes were found
to correlate with cognitive development.
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4. Discussion
4.1. Summary of main ﬁndings and strength of evidence
To our knowledge, this is the ﬁrst review to systematically assess the
predictive power of AERPs on neurodevelopmental outcome in the
population of preterm born infants.
Our results show that the majority of studies included in this review
reported signiﬁcant correlations between AERPs and neuropsycholo-
gical test scores, both in prospective and cross-sectional designs. A wide
range of auditory stimulation paradigms was used according to the
studies’ research questions and the age of their participants. While in
very young children passive paradigms were used, some studies with
older participants included attentional tasks during auditory stimula-
tion. Signiﬁcant correlations between AERPs and neurodevelopmental
outcome were found regardless of stimulation paradigm and participant
age. Only one study (Mikkola et al., 2010) did not ﬁnd any signiﬁcant
correlations between AERPs and outcome. However, the authors of this
study state that not all participants were able to complete the atten-
tional task which was linked to the AERP measurements; therefore the
used paradigm might have been too challenging for their study popu-
lation.
Two studies are of particular interest to this review, since they both
used a prospective design and were of suﬃcient methodological quality
according to our scoring system. Both studies recorded AERPs in the
neonatal period and administered the BSID at the age of 2 years. Weber
et al. (2016) found that habituation, as reﬂected by the decrease in
MMN over a 30-minute auditory stimulation period, signiﬁcantly pre-
dicted cognitive outcome in very preterm infants. Similarly, in the study
by Maitre et al. (2013), AERP amplitudes between 250–400ms after
stimulus onset predicted cognitive development on the BSID.
In general, shorter latencies and larger amplitudes of late AERP
peaks were related to a better cognitive outcome. This also applies for
the MMN in a simple oddball paradigm using tones or syllables.
However, in more complicated paradigms the interpretation of MMN is
diﬀerent: Jansson-Verkasalo et al. (2010) described that the presence of
MMN in a paradigm using native and non-native phoneme contrasts
indicates a deﬁciency of perceptual narrowing. Therefore in this para-
digm larger MMN amplitude was related to poorer vocabulary.
As many as eight prospective cohort studies investigated and sup-
ported the predictive capacities of AERPs for later mental development.
We therefore consider AERPs to be, at least to some extent, a viable,
simple, bedside applicable, cognitive assessment tool in neonates born
preterm. While our main research question was whether AERPS in
neonates could predict neurodevelopmental development at an older
age, cross-sectional studies of somewhat older children provided valu-
able information as well. Firstly, the inclusion of cross-sectional studies
increased the number of correlations between AERPs and neu-
ropsychological test scores and thereby allowed us to make a more
powerful statement regarding individual AERP components. Secondly,
a signiﬁcant correlation at a single point in time might strengthen the
assumption that neonatal AERPs also correlate with later neu-
ropsychological outcomes. Thirdly, including cross-sectional studies
increases the amount of information on AERPs in preterm born chil-
dren. Both the analysis of AERPs and the administration of neu-
ropsychological test batteries become easier as children grow older.
Overall, the studies included a range of preterm born infants. This
implies that moderate to late, very, but also extremely preterm infants
were included. This created a heterogeneous group of infants with
diﬀerent expected outcomes based on their gestational age (Boyle et al.,
2012; Glass et al., 2015). The included studies made intragroup com-
parisons based on birth weight (Fellman et al., 2004; Mikkola et al.,
2007), neonatal brain damage (Hovel et al., 2015; Leipala et al., 2011)
or cognitive performance (Jansson-Verkasalo et al., 2003, 2004),
however not based on gestational age. Therefore we were not able to
investigate the eﬀect of the degree of prematurity on the correlations
between AERPs and outcome.
4.2. General interpretation and context with other evidence
While the studies included in our review utilized a wide range of
auditory stimulation paradigms and heterogeneous cohorts, our ﬁnd-
ings corroborate previous reports of AERPs emerging as screening tools
for cognitive functioning (deRegnier, 2005, 2008). AERPs have been
successfully used to assess cognition in a range of other populations,
such as children at risk for dyslexia (Lyytinen et al., 2015; Molfese,
2000) or adults (Naatanen et al., 1997, 1993; Rugg and Coles, 1995).
Another use of AERPs is predicting the survival of neonates with brain
injuries. Studies emerging from this background also included data on
risk stratiﬁcation for neurodevelopmental outcome in preterm infants
(Pasman et al., 1997). The given outcomes, however, only provide
limited information regarding the predictive value of AERPs for cog-
nitive development.
The administration and interpretation of AERPs in neonates poses
several additional challenges when compared to adult populations: In
neonates, the typical AERP potentials may not be reliably detected, as
these positive and negative peaks do not appear until 1 year of age
(Kushnerenko et al., 2002). This fact is reﬂected by the variety of AERP
peaks investigated across the included studies. Mean amplitudes from
longer time windows post stimulus onset have been used in a neonatal
population (Maitre et al., 2013, 2014), yielding similar results as the
analysis of deﬁned AERP peaks. However, the deﬁnition of latency
windows for individual AERP peaks varied across studies. Especially in
the preterm population, longer latencies are found which reﬂect the
immaturity of the auditory processing in this group. With increasing
age, the latency is shown to decrease (Silva et al., 2017). Given the
variability in AERP responses in very young children (Kushnerenko
et al., 2002; Leppanen et al., 2004), we consider this heterogeneity to
be justiﬁed. Korpilahti et al. (2016) state that AERPs are more broadly
distributed in preterm born children than in those born at term. For this
reason, measuring AERPs at only a few positions might not discover all
relevant activity. However, more research is needed to establish a
consensus regarding the AERP characteristics that are most indicative
of cognition in newborns.
4.3. Strengths and limitations
The most apparent strength of this review is its systematic metho-
dology. A thorough search of relevant databases was conducted, and no
additional records were identiﬁed through hand-searching of reference
lists, which is an indicator that all eligible studies were identiﬁed
through our online search. While reviews have been published on this
topic, none of them were systematic. We based our critical appraisal
checklist on a standardized tool. By including both cross-sectional and
prospective study designs, we made sure to adequately depict today’s
state of knowledge regarding AERPs and cognitive development in
children born premature. Another strength of this review is the fact that
the majority of included studies used reliable tools for the measurement
of AERPs as well as neuropsychological outcome. Also, the testing
conditions for both prognostic factor and outcome measurement were
comparable across studies. This speaks to the fact that AERPs are a
feasible bedside test regardless of environmental circumstances, even in
neonates and infants. Finally, the reported outcomes were comparable
across all included studies, which supports the overall validity of our
ﬁndings.
However several limitations have to be acknowledged to our review
and the studies we included. We did not contact research teams di-
rectly, but relied solely on our search of online databases and reference
lists. As for the studies we included, it was striking to see that numerous
papers did not clearly explain their methodology and the factors which
were considered for the analyses. This made it diﬃcult for us to tell
whether non-signiﬁcant results for a certain outcome were not reported
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or whether there was no analysis conducted. Likewise they often did
not provide an interpretation of the correlations they found between
the AERPs and outcome tests.
For their correlations, one study (Jansson-Verkasalo et al., 2010)
used the MacArthur Communicative Development Inventories, which is
a parent questionnaire. While it is a standardized tool, the risk of bias
might be higher than in an assessment conducted by trained profes-
sionals. In another study (Leipala et al., 2011), neurodevelopmental
outcome was simply scored as normal, moderately abnormal, or se-
verely abnormal by a pediatric neurologist. The same study reported
the number of AERP variables correlating with neurodevelopmental
outcome without mentioning which variables those were. While clini-
cally relevant, these results do not allow for an easy reproduction of the
study ﬁndings. Another two studies reported their results in a narrative
fashion (Jansson-Verkasalo et al., 2004) and calculated the probability
of having abnormal AERPs in the presence of naming diﬃculties
(Jansson-Verkasalo et al., 2003). Further, the preterm born cohorts
were heterogeneous regarding age and clinical diagnoses. Across the 13
published papers we included, the number of preterm born children
examined was just short of 300 - which is a relatively small number.
Some studies had such small sample sizes that it was not possible to
calculate adequate statistical correlations. In addition the number of
preterm born infants who underwent an AERP-assessment around term
equivalent age was very limited. Only few research groups are in-
vestigating the prediction of cognition in prematurely born children,
which means that the bulk of evidence comes from only a handful of
clinical centers with some overlap between study cohorts. Another
limitation is the fact that, due to the rapid advancement in AERP
methodology, some older studies pertaining to this topic could not be
compared to studies using the newest techniques. A more general
limitation to our review is the overall poor quality of prognostic studies
compared to other study designs (Altman, 2001).
4.4. Implications for clinical practice and future research
Prematurity is a known risk factor for the occurrence of cognitive
deﬁcits (Bhutta et al., 2002). Neonatologists, pediatricians and devel-
opmental psychologists are in daily contact with parents of preterm
born infants who are worried about their child’s cognitive development
(Howe et al., 2014). Therefore a tool that allows early identiﬁcation is
needed in clinical practice. The earlier patients at risk are identiﬁed, the
earlier an intervention can start and possibly the better the outcomes
will be (Spittle et al., 2015). The most advantageous features of EEG are
that it is a non-invasive and bedside functional neuroimaging tool. Due
to the long hospitalization duration, it is feasible to perform an AERP-
assessment with premature infants. However few studies have focused
on AERPs recorded in the neonatal period and the ones who did are
quite diverse. In general based on the ﬁve prospective studies con-
taining neonatal AERPs, larger peaks and shorter latencies were related
to a better cognitive outcome. None of those studies provided cut-oﬀ
levels based on sensitivity or speciﬁcity analyses. Recommendations for
diﬀerent levels of prematurity cannot be made due to the heterogeneity
of the study participants.
Most of the studies utilized an auditory oddball paradigm with tones
or syllables to investigate diﬀerent AERP peaks and components. One
study (Jansson-Verkasalo et al., 2010) reported that not all preschool-
aged participants were able to complete a rather complex attentional
task. This might imply that across all age groups, simple auditory tasks
such as an oddball paradigm should be used in order to avoid con-
founding by individual performance levels.
All included studies except for one reported signiﬁcant correlations
between AERP measurements and cognitive development. This ﬁnding
should encourage more in-depth research in this ﬁeld in order to es-
tablish the clinical use of AERPs for the purpose of cognitive assessment
in premature infants.
This systematic review does not report enough data to be translated
into normative data or cut-oﬀ values. More studies with similar cohorts
and methods are needed as well as sensitivity and speciﬁcity analyses in
order to establish individual routine screening. Larger sample sizes also
improve the power; therefore performing multicenter studies can be
helpful. Additionally, more prospective cohort studies, starting at
neonatal age, with longer follow-up periods are required. As well as the
elaboration of guidelines (Duncan et al., 2009; Picton et al., 2000) for
the predictive use of AERPs in the preterm population. Such guidelines
can serve as the base for the development of a clinical test consisting of
well-deﬁned parameters.
5. Conclusion
The present systematic review investigates the predictive power of
AERPs in preterm born infants. Our ﬁndings highlight the potential use
of this method in an at risk population. Overall it was found that larger
amplitudes and shorter latencies of late AERPs are related to better
cognitive outcomes. In order to clinically apply this method, more
evidence based on high quality studies is needed.
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Appendix A
Search strategy
Pubmed
Keyword and Medical Subject Headings Search
((((((preterm*[Text Word] OR premature*[Text Word] OR very low birth weight*[Text Word]))) AND ((neonat*[Text Word] OR newborn*[Text
Word] OR infant*[Text Word] OR toddler*[Text Word] OR child*[Text Word] OR adolescent*[Text Word] OR preschool*[Text Word] OR school-
age*[Text Word]))) AND ((((event-related potential*[Text Word] OR auditory evoked potential*[Text Word] OR mismatch respons*[Text Word] OR
mismatch negativit*[Text Word] OR contingent negative variation*[Text Word] OR evoked cortical respons*[Text Word]))) OR (((N1[Text Word]
OR N100[Text Word] OR P2[Text Word] OR P200[Text Word] OR P300[Text Word] OR ERP*[Text Word] OR MMN*[Text Word] OR CNV*[Text
Word])) AND (EEG*[Text Word] OR electroencephalogr*[Text Word]))))) OR (((((("Premature Birth"[Mesh]) OR "Infant, Premature"[Mesh]) OR
"Infant, Very Low Birth Weight"[Mesh])) AND ((((("Infant, Newborn"[Mesh]) OR "Infant"[Mesh]) OR "Child"[Mesh]) OR "Child, Preschool"[Mesh])
OR "Adolescent"[Mesh])) AND ((("Event-Related Potentials, P300"[Mesh]) OR "Evoked Potentials, Auditory"[Mesh]) OR "Contingent Negative
Variation"[Mesh])).
Embase
Keyword and Emtree Search
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1 'preterm*':ab,ti OR 'prematur*':ab,ti OR 'very low birth weight*':ab,ti
2 'neonat*':ab,ti OR 'newborn*':ab,ti OR 'infant*':ab,ti OR 'toddler*':ab,ti OR 'child*':ab,ti OR 'adolescent*':ab,ti OR 'preschool*':ab,ti OR 'school-
age*':ab,ti
3 'event-related potential*':ab,ti OR 'auditory evoked potential*':ab,ti OR 'mismatch respons*':ab,ti OR 'mismatch negativit*':ab,ti OR 'contingent
negative variation*':ab,ti OR 'evoked cortical respons*':ab,ti
4 'n1':ab,ti OR 'n100':ab,ti OR 'p2':ab,ti OR 'p200':ab,ti OR 'p300':ab,ti OR 'erp*':ab,ti OR 'mmn*':ab,ti OR 'cnv*':ab,ti AND ('eeg*':ab,ti OR 'elec-
troencephalogr*':ab,ti)
5 #3 OR #4
6 #1 AND #2 AND #5
7 'newborn'/exp OR 'infant'/exp OR 'child'/exp OR 'adolescent'/exp
8 'immature and premature labor'/exp OR 'very low birth weight'/exp
9 'event related potential'/exp OR 'auditory evoked potential'/exp OR 'evoked cortical response'/exp
10 #7 AND #8 AND #9
11 #6 OR #10
PsycINFO
Keyword and Thesaurus Search
1 (preterm* or premature* or very low birth weight*).mp. [mp= title, abstract, heading word, table of contents, key concepts, original title, tests &
measures]
2 (neonat* or newborn* or infant* or toddler* or child* or adolescent* or preschool* or school-age*).mp. [mp= title, abstract, heading word, table
of contents, key concepts, original title, tests & measures]
3 (event-related potential* or auditory evoked potential* or mismatch respons* or mismatch negativit* or contingent negative variation* or evoked
cortical respons*).mp. [mp= title, abstract, heading word, table of contents, key concepts, original title, tests & measures]
4 (N1 or N100 or P2 or P200 or P300 or ERP* or MMN* or CNV*).mp. [mp= title, abstract, heading word, table of contents, key concepts, original
title, tests & measures]
5 (EEG* or electroencephalogr*).mp. [mp= title, abstract, heading word, table of contents, key concepts, original title, tests & measures]
6 4 and 5
7 3 or 6
8 1 and 2 and 7
9 evoked potentials/ or auditory evoked potentials/ or contingent negative variation/ or mismatch negativity/ or p300/
10 birth weight/ or premature birth/
11 9 and 10
12 8 or 11
2. QUIPS-adapted appraisal checklist
Item Criteria Score
Participation a Adequate description of recruitment and participation (min. n= 20) a.
a Adequate description of study sample b.
a Adequate description of inclusion and exclusion criteria c.
total:
Attrition a Adequate percentage returning for follow-up (> 50%) a.
a Adequate description of participants lost to follow-up b.
a Participants lost to follow-up did not diﬀer signiﬁcantly from participants who completed the follow-
up
c.
total:
Prognostic Factor
Measurement*
a The prognostic test / prognostic factor was adequately described a.
a The prognostic test conditions were equal for all participants b.
a Adequate proportion of the study sample has complete data c.
total:
Outcome Measurement a The outcome is clearly deﬁned a.
a Adequate administration of outcome measurement across participants b.
a Outcome measure is a standardized validated test c.
total:
Study Confounding a Adequate description and measurement of relevant confounders a.
a Important potential confounders are accounted for b.
a Authors report possible study limitations c.
total:
a Suﬃcient data presented to assess analytic strategy a.
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Statistical Analysis and
Reporting
a Adequate selection of statistical model b.
a No selective reporting of results c.
total:
Scoring: 1 point for each criterion fulﬁlled.
*ERPs.
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Abstract
The aim of this prospective pilot study was to evaluate the predictive value of discrimination and habituation, which was measured
by mismatch negativity in 17 healthy very preterm (mean gestational age 27.4 weeks; range 25.0-31.3) and 16 term (mean
gestational age 40.3 weeks; range 37.9-41.7) born infants at term equivalent age. Developmental outcome was measured by Bayley
Scales of Infant Development–I in 13 preterm and 13 term-born children at a mean age of 21.7 months (+2.18) and 18.5 months
(+1.9), respectively. No differences in amplitude and latency of the mismatch negativity were found between both groups at term
equivalent age. Within the preterm group habituation capacity was positively correlated with the Mental Developmental Index
(r ¼ .654, P ¼ .008) and Performance Developmental Index (r ¼ .482, P ¼ .048) at 21 months. Early learning capability, as
measured by habituation, may be associated with a better prognosis for early mental development in healthy preterm infants.
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Preterm birth is the main cause of infant mortality and a very
important risk factor for the development of intellectual dis-
ability.1 Whereas individual prediction of cerebral palsy—the
severe form of a movement disorder following prematurity—
by clinical bedside procedures is already possible with suffi-
cient validity within the first 3 to 6 months of life,2,3 accurate
identification of individual children with increased risk for
cognitive impairments is still a challenge because of the diffi-
culties in finding any valid bedside tests of estimating cognitive
abilities in infancy.4 Closing this diagnostic gap is therefore of
utmost clinical importance in long-term follow-up of preterm
children.5 Early identification of preterm infants at risk for
neuropsychological sequelae is particularly relevant because
early intervention programs are found to be effective up to
preschool age.6 Even if the concept of brain plasticity recom-
mends an early start of intervention, ‘‘high rate of attrition in
routine clinical follow-up and consequent difficulty in accu-
rately determining rates of delay highlight challenges for cen-
ters providing ongoing care.’’7 Offering these programs to all
very preterm children is not feasible in many countries due
to limited resources. In addition in some countries, such as
Switzerland, a routine evaluation of the development of pre-
term infants is offered, but not an early intervention for all
children. Thus, there is potential need to develop diagnostic tools
which allow risk-stratification by early identification of preterm
infants at increased risk for mental impairment, who might pos-
sibly benefit the most from such intervention programs.
Numerous studies show that several event-related compo-
nents in an auditory oddball paradigm are easily measurable
and indicative of mental functioning in neonates.8-11 Moreover
sound discrimination tasks, used in the neonatal intensive care
unit, appear to be predictive of cognitive outcome in preterm
infants at 2 years of age.12 Such an auditory oddball paradigm
consists of presenting sequences of repetitive ‘‘standard’’
tones, sporadically interrupted by ‘‘deviant’’ tones, resulting
in an auditory event-related potential component called mis-
match negativity. This event-related potential component is
calculated by subtracting the average event-related potential
of the standard tones from the average event-related potential
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of the deviant tones. The by subtraction resulting difference
waveform is known to have a negative amplitude peaking
between 100 and 250 ms post deviant stimulus onset in
adults.13 It is interpreted as a preattentive cognitive discrimi-
nation ability and can already be observed from 30 weeks of
gestational age onward.14
Preterm infants may show a diminished capability for habi-
tuation and dishabituation as early signs of delay in mental
processing such as encoding, attention, discrimination, and
memory.15 Nevertheless until now habituation and its predic-
tive value for later mental development of very preterm chil-
dren has not yet been studied in an electrophysiological setting.
Therefore the authors aimed to assess discrimination, as an
early preattentive parameter, and habituation, as an early para-
meter of learning, measured by auditory event-related poten-
tials in very preterm compared to healthy term-born infants in a
clinical routine setting. To test the predictive value of habitua-
tion in preterm infants at term-equivalent age for the mental
development, authors correlated the habituation capability at
this age, measured by the difference in mismatch negativity,
with the developmental level at corrected age of 21 months.
Methods
Participants and Procedure
In this prospective pilot study preterm infants were recruited at the
Neonatal Intensive Care Unit of the University Children’s Hospital
Basel and healthy term-born infants were recruited at the child-bed
ward of the Division of Gynaecology and Obstetrics of Bruderholz-
spital in the canton Basel-Landschaft. The authors examined 17 very
preterm infants and 16 healthy term-born infants at a mean gestational
age of 40.8 weeks (range 38.1-43.0). Preterm infants with severe brain
lesions (ie, > grade II intracerebral hemorrhages, neonatal seizures),
genetic syndromes, or confirmed congenital infection were excluded
from the study to avoid a heterogeneous cohort. The cohort charac-
teristics are documented in Table 1. Routinely in all infants and neo-
nates transient-evoked otoacoustic emissions were recorded and
analyzed, before discharge from the hospital (36-42 weeks of gesta-
tional age). All participants fulfilled the ‘‘pass’’ criterion. Even if this
procedure doesn’t allow to quantify the hearing level, it is accepted to
be demonstrating a normal cochlear function.16
Follow-up was conducted and 13 preterm and 13 term-born chil-
dren were tested with regard to developmental outcome at a cor-
rected mean age of 21.7 months (+2.18) and 18.5 months (+1.9),
respectively. Thus there was a drop-out of 4 preterm and 3 term-born
children due to moving of the families, including 1 family with
preterm triplets.
The Ethics Committee of Basel approved the study protocol, par-
ents gave written informed consent, and the study has been carried out
in accordance with the Declaration of Helsinki.
Auditory Event-Related Potentials
The auditory event-related potentials were conducted with electrodes
located according to the International 10-20 system at midline elec-
trode sites (Fz, Pz, and Oz) and referenced to the left-sided mastoid
electrode A1. To control for artifacts by eye movements, 1 electrode
was located at the lower outer side of the left eye. The passive auditory
oddball paradigm was used in the study to elicit auditory event-related
potentials. It consists of presenting 2 tones with different frequencies
(Hz). The standard (ie, frequently occurring) tone was 1000 Hz and the
deviant (ie, rarely occurring) tone 2000 Hz, both presented in a
pseudo-randomized order. The standard tone occurred with a prob-
ability of 85%, while the deviant tone occurred with a probability of
15%. The stimulus frequency was 0.9 Hz and the intensity 80 dB
normal hearing level. In the experimental setting, 3 blocks of 500
tones were presented via headphones to the silent awake or sleeping
infants. A break of 2 minutes was taken between each block. The
event-related potentials were recorded with the Viking Select
4-channel in a bedside setting. Even if the use of this simple equip-
ment with only 4 active electrodes implicated some limitations, such
as renouncement of information about laterality or automatically
grand averaging, it was used since it is an equipment which is avail-
able in the clinical setting of nearly all Neonatal Intensive Care Units,
underlining the aspect of the feasibility of this data collection in daily
routine on the ward. The data were acquired offline with a band-pass
filter of 0.5-40 Hz and a sampling rate of 20 kHz.
Data Analysis
The artifact rejection was performed manually per stimulation block.
Samples with an amplitude difference between rare and frequent tones
of >0.5 mV at the electrode under the eye were excluded, as indication
of a relevant influence by eye blinks. The electrophysiological
response was then averaged over the standard and the deviant tones
independently for each of the 3 stimulus blocks.
To compute the mismatch negativity, at first the authors manually
identified the peak of the event-related potential in the time window
between 150 and 300 ms after stimulus presentation for every pro-
band. Thereafter the differences of the amplitude between rare
and frequent tones were calculated, defining the mismatch negativity
(Figure 1). The resulting mismatch negativity is investigated regarding
amplitude (in mV), latency (in ms) and polarity (negative or positive)
and corresponds to the discrimination ability of the subjects. The
habituation capability is then calculated by the difference in amplitude
of mismatch negativity between the first and third stimulus block.
Table 1. Cohort Characteristics: Group Differences Tested by Unpaired t-Test and Chi-Quadrat Test.
Preterm infants (n ¼ 17) Term-born infants (n ¼ 16) P value
GA at birth, mean (range) 27.4 weeks (25.0-31.3) 40.3 weeks (37.9-41.7) <.001*
GA at examination, mean (range) 40.8 weeks (38.4-43.0) 40.8 weeks (38.1-42.0) .943
Sex (m: f) 9: 8 10: 6 .257
Birth weight, mean (range) 893 g (470-1530) 3603 g (2880-4300) <.001*
Abbreviations: f, female; GA, gestational age; m, male.
*P < .05.
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Developmental Outcome
The developmental outcome was measured by the Bayley Scales of
Infant Development–I17 and the Mental Developmental Index and
Performance Developmental Index were computed. The examiners
were blinded with regard to the electrophysiological data.
Statistical Analysis
Statistical computations were performed using SPSS version 22.0
(IBM) for Windows. Pearson’s chi-square test, calculation of Pear-
son’s correlation coefficient, or t-test for independent cohorts were
used accordingly. The significance level was set at P < .05 (2-tailed).
In respect to the proof-of-concept initiation of the study and the
small sample size, no Bonferroni corrections were applied.
Results
Mismatch Negativity
No significant group differences in latency or mean amplitude
of the mismatch negativity were found at the midline electrodes
between preterm and term-born infants. However, significantly
more preterm infants showed a lower arbitrary chosen mis-
match negativity amplitude of < 2 mV (w2 ¼ 4.29, P ¼ .038)
at Fz compared to term infants. In addition no significant dif-
ference was found in the habituation effect calculated by the
difference in mismatch negativity between first and third
stimulus blocks, just as no difference was observed in the fre-
quency of a habituation or dishabituation effect between the
groups (Table 2).
Outcome
The developmental outcome measured by Bayley Scales of
Infant Development–I showed significant differences between
the preterm and control group. In particular, both groups dif-
fered significantly on the Mental Developmental Index
(74+18.28 in the preterm group vs 95+10.78 in the control
group), t(19.5) ¼ 3.49, P ¼ .002, and the Performance Devel-
opmental Index (89+13.01 in the preterm group vs 109+8.9
in the control group), t(24) ¼ 4.57, P < .001. No differences
were found in the behavioral scales: orientation, t(23) ¼ –0.30,
P ¼ .766, emotion, t(23) ¼ 2.02, P ¼ .568, or motor quality,
t(23) ¼ 2.14, P ¼ .43.
Correlations
Within the group of preterm infants no significant correlation
was found between gestational age and amplitude or latency of
mismatch negativity at any of the 3 electrode positions. How-
ever gestational age significantly correlated with difference in
mismatch negativity at electrode position Fz (r ¼ .551, P ¼
.013), Cz (r ¼ .531, P ¼ .017), and Pz (r ¼ .478, P ¼ .031)
(Table 3; Figure 2).
With regard to the developmental outcome test, the Mental
Developmental Index was significantly correlated with differ-
ence in mismatch negativity at the electrode position Cz (r ¼
.654, P ¼ .008), but not at position Fz (r ¼ .313, P ¼ .149) or
Pz (r ¼ .145, P ¼ .319). The Performance Developmental
Index was also significantly correlated with difference in mis-
match negativity at position Cz (r ¼ .482, P ¼ .048), but no
correlation was observed between the Performance Develop-
mental Index and difference in mismatch negativity at position
Fz (r¼ .157, P¼ .304) and Pz (r¼ –.047, P¼ .439) (Figure 3).
Discussion
The main finding of this study is the association between the
habituation capability (difference in mismatch negativity) and
the mental and performance outcome subtest at the age of 21
months within the group of preterm infants. This positive rela-
tion suggests that the lower the habituation effect, the lower the
scores on the mental and performance scale. The relationship
between event-related potential components and the Bayley
Scales of Infant Development–I highlights the power of audi-
tory event related measures in prediction of cognitive abil-
ities,8,9,18 although the authors have taken into account the
low statistical power of this study including the fact that no
Bonferroni correction considering the number of electrodes
was done, which would decrease the statistical significance.
Other studies have found similar relationships between audi-
tory event-related potentials and cognitive outcomes even at
later ages.10,12 The authors examined habituation, a variable
Figure 1. Example of an averaged auditory event-related potential
(AERP) of the first stimulus block of 1 participant. The maximum
amplitude peaks between 150-300 ms are indicated at the midline
electrodes (Fz, Cz, Pz) for rare (R, n ¼ 75) tones and the corre-
spondent amplitude value for frequent (F, n ¼ 425) tones. By sub-
tracting these amplitude values respectively, the mismatch negativity
(MMN) component is calculated.
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that has not been adequately assessed in previous studies using
auditory event-related potentials in preterm children. In an
older behavioral study19 fast movement habituation was found
to be related to higher scores on the Mental Developmental
Index. Habituation is regarded as the most elementary form
of learning and can be observed in neonates in behavioral stud-
ies15 as well as in neuroimaging studies.18,20 Since the compe-
tence of learning is an important constituent of cognitive
development, it is a potentially useful predictor of neurodeve-
lopmental outcomes in infants at greatest risk for cognitive
impairment.20
This pilot study points to the possible early predictive value
of habituation measured by mismatch negativity for later indi-
vidualized developmental outcomes in very preterm infants.
Moreover, it implies that this procedure might be useful as a
simply applicable risk stratification tool in a bedside setting.
The fact that the closest correlation between the developmental
level at age of 21 months and the habituation effect was docu-
mented at the Cz lead, could evoke some suggestions about the
cortical function involved in the tasks. In respect of the small
head circumference of the infants as well as the insufficient
spatial resolution of electroencephalography from scalp elec-
trodes, the authors disclaim this speculation at this point.
In contrast to most studies with larger samples sizes,21 in
this study the authors found no differences regarding amplitude
or latency of mismatch negativity in a passive auditory oddball
paradigm between very preterm and term-born infants at neo-
natal age. Even though no significant group differences were
found in mean values, using an arbitrary cut off amplitude
value of < 2 mV more control infants exceeded this mismatch
negativity limit than preterm infants. Often it is reported that
the lower the gestational age, the lower the event-related poten-
tial amplitudes.21 Lower amplitudes might indicate lower capa-
cities in detection of sound differences, meaning a less
preattentive discrimination ability, and therefore immaturity
of the auditory system.22 Consequently the current results sug-
gest that only a subgroup of very preterm infants show reduced
mental processing during discrimination tasks. In this way,
measuring habituation as a possible predictor of cognitive
impairment in early infancy might open the window for more
targeted follow up neurodevelopmental therapies in certain
newborns.
Contrary to what might have been expected the habituation
capacity—defined by the reduction of the mismatch negativity
amplitude between the first and third session—did not differ
among the preterm as compared to the control children, neither
between the first and second stimulus block, nor between the
first and third stimulus block. As a limitation of the authors’
technical methods, the authors could not analyze a possible
Table 2. Latency, Amplitude, Frequency of Low Mismatch Negativity (MMN) Amplitudes (<2 mV), Difference of the Amplitude (Habituation
Effect) of MMN Between the First and Second (dMMN 1-2) and Between the First and the Third Stimulus Block (dMMN 1-3), and Frequency of
Dishabituation in Both Groups at the 3 Electrode Positions Fz, Cz, and Pz after Unpaired t-Tests.
Preterm infants (n ¼ 17) Term-born infants (n ¼ 16) P value
Fz MMN latency (ms) (mean+ SD) 220.9+ 42.8 234.9+ 27.3 .275
MMN amplitude (mV) (mean+ SD) 3.27 + 1.88 4.08 + 1.71 .205
Frequency MMN amplitude < 2 mV
dMMN 1-2 amplitude (mV) (mean + SD)
Frequency of dishabituation
4/17
–0.01+ 1.53
8/17
0/16
0.75 + 1.93
6/16
.038*
.236
.740
dMMN 1-3 amplitude (mV) (mean + SD) 0.42 + 3.36 1.33 + 1.56 .330
Frequency of dishabituation 7/17 3/16 .127
Cz MMN latency ms (mean + SD) 204.3+ 21.7 213.3+ 20.5 .230
MMN amplitude (mV) (mean+ SD) 4.22 + 2.79 4.65 + 2.35 .644
Frequency MMN amplitude < 2 mV
dMMN 1-2 amplitude (mV) (mean + SD)
Frequency of dishabituation
4/17
0.43 + 2.50
7/17
1/16
1.17 + 2.38
5/16
.144
.406
.849
dMMN 1-3 amplitude (mV) (mean + SD) 0.63 + 3.32 0.65 + 2.77 .986
Frequency of dishabituation 9/17 6/16 .288
Pz MMN latency ms (mean + SD) 213.9+ 36.9 205.0+ 27.2 .438
MMN amplitude (mV) (mean+ SD) 2.90 + 1.41 3.08 + 1.70 .743
Frequency MMN amplitude < 2 mV
dMMN 1-2 amplitude (mV) (mean + SD)
Frequency of dishabituation
5/17
0.20 + 1.44
9/17
4/16
1.0 + 1.78
7/16
.694
.179
.777
dMMN amplitude (mV) (mean + SD) 0.23+ 1.68 0.30 + 2.02 .915
Frequency of dishabituation 7/17 8/16 .723
*P < .05.
Table 3. Pearson Correlations Between Gestational Age at Birth
(GA), Mental Developmental Index (MDI), and Performance
Developmental Index (PDI) and the Difference Between MMN During
the First and the Third Stimulus Block (dMMN ¼ Habituation Effect).
GA MDI PDI
dMMN (mV) at Fz .551* .313 .157
dMMN (mV) at Cz .531* .654* .482*
dMMN (mV) at Pz .478* .154 .047
*P < .05.
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habituation effect within 1 single (ie, the first) stimulus block.
It is possible that habituation is a fast learning process, which
could be detected only in a short time window. In addition, the
failure to replicate this result might be due to limited statistical
power in the present study and the fact that only a subgroup of
preterm infants at higher risk might show this deficiency.
As expected, very preterm children showed lower scores in
mental development compared to children born at term which
is in line with existing evidence.23,24
Furthermore, difference in mismatch negativity was also
related to the gestational age, meaning the earlier the infant
is born, the lower the habituation effect and vice versa. Gesta-
tional age is an important risk factor in general and known to
correlate with cognitive outcomes.12 Therefore in a larger sam-
ple size difference in mismatch negativity has to be confirmed
as independent predictive variable. In addition infants with
prematurity under 25 gestational weeks and higher risk of neu-
rodevelopmental problems should be included for further test-
ing the discussed hypothesis.
Beside the small sample size, the main constraint of this pilot
study is that only 3 electrode positions were used and therefore
does not provide us with many strong correlations between the
event-related potential components and the mental outcome test.
Moreover the low number of participants and the drop-out for
the outcomemeasurement at the age of 21 months leaves us with
less data to support the prediction hypothesis. The outcome was
only investigated in early childhood, so data from the subjects at
a later age in their development would be interesting.
In conclusion, this proof-of-concept pilot study suggests the
auditory event-related potential approach as a potentially valu-
able tool to assess early cognitive abilities, such as habituation,
in neonates in a bedside setting.
Figure 2. Simple linear regression of the amplitude difference between mismatch negativity (MMN) in the first stimulus block minus MMN in the
third stimulus block (¼ habituation effect, dMMN) and gestational age at electrode position Fz (A), Cz (B), and Pz (C).
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Abstract: Neurofilament light chain (NfL) is a highly promising biomarker of 
neuroaxonal injury that has mainly been studied in adult neurodegenerative disease. 
Its involvement in neonatal disease remains largely unknown. Our aim was to 
establish NfL plasma concentrations in preterm and term infants in the first week of 
life. Plasma NfL was measured by single molecule array immunoassay in two 
neonatal cohorts: cohort 1 contained 203 term and preterm infants, median 
gestational age (GA) 37.9 weeks (interquartile range [IQR] 31.9-39.4), in whom 
venous and arterial umbilical cord blood was sampled at birth and venous blood at 
day of life (DOL) 3; cohort 2 contained 98 preterm infants, median GA 29.3 weeks 
(IQR 26.9-30.6), in whom venous blood was sampled at DOL 7. Median NfL 
concentrations in venous blood increased significantly from birth (18.2 pg/mL [IQR 
12.8-30.8, cohort 1]) to DOL 3 (50.9 pg/mL [41.3-100, cohort 1]) and DOL 7 (126 
pg/mL [78.8-225, cohort 2]) (p<.001). In both cohorts NfL correlated inversely with 
birth weight (BW, Spearman’s rho -.403, p<.001, cohort 1; R -.525, p<.001, cohort 2) 
and GA (R -.271, p<.001, cohort 1; R -.487, p<.001, cohort 2). Additional significant 
correlations were found for maternal age at delivery, preeclampsia, delivery mode, 5-
min Apgar, duration of oxygen supplementation, sepsis, and brain damage 
(intraventricular hemorrhage or periventricular leukomalacia). Multivariable logistic 
regression analysis identified the independent predictors of NfL in cohort 1 as BW 
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(beta=-.297, p=.003), delivery mode (beta=.237, p=.001) and preeclampsia 
(beta=.183, p=.022) and in cohort 2 as BW (beta=-.385, p=.001) and brain damage 
(beta=.222, p=.015). Neonatal NfL levels correlate inversely with maturity and BW, 
increase during the first days of life, and relate to brain injury factors such as 
intraventricular hemorrhage and periventricular leukomalacia, and also to vaginal 
delivery. 
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Peter Weber 1, Jens Kuhle 3 and Sven Wellmann 2
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Background: Neurofilament light chain (NfL) is a highly promising biomarker of
neuroaxonal injury that has mainly been studied in adult neurodegenerative disease. Its
involvement in neonatal disease remains largely unknown. Our aim was to establish NfL
plasma concentrations in preterm and term infants in the first week of life.
Methods: Plasma NfL was measured by single molecule array immunoassay in two
neonatal cohorts: cohort 1 contained 203 term and preterm infants, median gestational
age (GA) 37.9 weeks (interquartile range [IQR] 31.9–39.4), in whom venous and arterial
umbilical cord blood was sampled at birth and venous blood at day of life (DOL) 3; cohort
2 contained 98 preterm infants, median GA 29.3 weeks (IQR 26.9–30.6), in whom venous
blood was sampled at DOL 7.
Results: Median NfL concentrations in venous blood increased significantly from birth
(18.2 pg/mL [IQR 12.8–30.8, cohort 1]) to DOL 3 (50.9 pg/mL [41.3–100, cohort 1]) and
DOL 7 (126 pg/mL [78.8–225, cohort 2]) (p < 0.001). In both cohorts NfL correlated
inversely with birth weight (BW, Spearman’s rho −0.403, p < 0.001, cohort 1; R
−0.525, p < 0.001, cohort 2) and GA (R −0.271, p < 0.001, cohort 1; R −0.487,
p < 0.001, cohort 2). Additional significant correlations were found for maternal age at
delivery, preeclampsia, delivery mode, 5-min Apgar, duration of oxygen supplementation,
sepsis, and brain damage (intraventricular hemorrhage or periventricular leukomalacia).
Multivariable logistic regression analysis identified the independent predictors of NfL in
cohort 1 as BW (beta = −0.297, p = 0.003), delivery mode (beta = 0.237, p = 0.001)
and preeclampsia (beta = 0.183, p = 0.022) and in cohort 2 as BW (beta = −0.385,
p = 0.001) and brain damage (beta = 0.222, p = 0.015).
Conclusion: Neonatal NfL levels correlate inversely with maturity and BW, increase
during the first days of life, and relate to brain injury factors such as intraventricular
hemorrhage and periventricular leukomalacia, and also to vaginal delivery.
Keywords: cerebral injury, neuropathology, biomarker, infant, parturition, prematurity
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INTRODUCTION
As direct access to the central nervous system (CNS) is
almost impossible, neuronal biomarkers have been investigated
for decades in order to improve early diagnostics, monitor
disease progression and optimize care. Neurofilaments (Nf) are
highly specific major neuronal scaffolding proteins comprising 4
subunits: the triplet of Nf light chain (NfL), Nf medium chain,
and Nf heavy chain (NfH), and α-internexin in the CNS, or
peripherin in the peripheral nervous system (1). Acute or chronic
neuronal damage, including traumatic brain injury, stroke,
dementia and multiple sclerosis, releases Nf fragments into the
cerebrospinal fluid and eventually the blood compartment (2–
6). Recent advances using highly sensitive single molecule array
(Simoa) immunoassay have improved NfL detection, particularly
in peripheral blood, making it a promising and readily accessible
biomarker for neuroaxonal injury (7).
Whereas, circulating Nf has been extensively characterized in
adults and older children with neurologic disease, data in infants
and particularly newborns are sparse. One study reported raised
serum NfH in children older than 6 months with febrile seizures
lasting >30min, suggesting that prolonged seizures cause some
degree of neuronal damage (8). Plasma NfH in newborns with
hypoxic-ischemic encephalopathy (HIE) was also higher than
in healthy neonates (9, 10). Moreover, NfL levels in infants
undergoing therapeutic hypothermia for HIE were significantly
higher in those with unfavorable vs. favorable brain magnetic
resonance imaging (MRI) outcome (11). As for mode of delivery,
serum NfH levels at day of life (DOL) 2 in a small cohort of
newborns did not differ between those born vaginally and those
born by cesarean section (12).
Given the potential of Nf in adults with acute or chronic CNS
damage and promising results in infants with HIE, we aimed to
measure NfL levels by Simoa in two cohorts of preterm and term
neonates in umbilical cord blood at birth and in venous blood a
few days after birth.
MATERIALS AND METHODS
Study Participants
The study was based on data and blood samples prospectively
collected from two neonatal cohorts. Cohort 1 comprised data
and blood samples from 203 preterm and term neonates, median
gestational age (GA) 37.9 weeks (interquartile range [IQR]
31.9–39.4), born and cared for at the University Hospitals of
Zurich and Basel, Switzerland. More specifically, it comprised 89
preterm infants (GA < 37 weeks), including 52 with GA < 32
weeks, and 114 term infants (GA ≥ 37 weeks). The study was
approved by the institutional review boards of both university
hospitals (Ethikkommission beider Basel, EKBB07/09, Kantonale
Ethikkommission Zurich, KEK08/09). Cohort 2 comprised data
and blood samples from 98 very preterm neonates (GA < 32
weeks), median GA 29.3 weeks (IQR 26.9–30.6), born and cared
Abbreviations: Nf, Neurofilament; NfL, Neurofilament Light Chain; GA,
Gestational Age; BW, Birth Weight; DOL, Day of Life; MPT, Moderate Preterm
and Term.
for at the University Hospital of Basel, Switzerland. The study was
approved by the institutional review board (Ethikkommission
beider Basel, EK233/13) and was carried out in accordance
with the declaration of Helsinki. Written informed consent was
obtained from the parents prior to enrollment.
Clinical Characteristics (Table 1)
Details of pregnancy (presence/absence of preeclampsia,
amniotic infection, preterm labor, maternal age, premature
rupture of membranes), delivery (umbilical artery pH, delivery
modality), birth (GA, BW, sex, 5- and 10-min Apgar scores),
and postnatal course to discharge home (presence/absence of
sepsis and/or necrotizing enterocolitis, ultrasound brain damage
with periventricular intraventricular hemorrhage [PIVH] or
periventricular leukomalacia [PVL], duration of oxygen) were
collected from the charts. Definitions of clinical characteristics,
including preeclampsia, clinical chorioamnionitis, PIVH, and
PVL, have been described previously (13), based on standardized
definitions of the Swiss Neonatal Network.
Sample Preparation and Assessment of
NfL
In cohort 1, venous blood (0.5mL) was collected from the
umbilical cord at birth (n = 185) and simultaneously with
mandatory neonatal metabolic screening at DOL 3 (n = 39);
68 paired umbilical arterial samples were also collected at birth.
In cohort 2, venous blood was collected with diagnostic blood
samples at DOL 7 (n = 98). All samples were handled according
to standard operating procedures for blood sampling in EDTA
tubes, subsequent sample transfer to the central laboratory
service, centrifugation, preparation of aliquots, and storage at
−80◦C until batch-wise analysis as described previously (14).
Assay technicians were blinded to clinical information and
pregnancy outcome.
NfL levels were measured by Simoa immunoassay using
capture monoclonal antibody (mAB) 47:3 and biotinylated
detector mAB 2:1 (UmanDiagnostics, Umea, Sweden), as
previously described (15). Calibrators (neat) and serum samples
(1:4 dilution) were measured in duplicate. Bovine lyophilized
NfL was obtained from UmanDiagnostics. Calibrators ranged
from 0 to 2,000 pg/mL. Batch-prepared calibrators were stored
at −80◦C. Intra- and interassay variabilities were < 10%; the
few samples with intra-assay coefficients of variation >20% were
remeasured.
Data Analysis
Statistical analyses were performed using SPSS for Windows
version 24 (IBM) and included descriptive statistics, Spearman’s
rank-order correlation analyses and multiple linear regressions
(MLR) using NfL as dependent variable. NfL variables were log10
transformed for the correlations and MLR. The independent
variables included forMLRwere based on significant correlations
and significant non-parametric univariate analyses such as the
Mann-Whitney U (2 levels) and Kruskal-Wallis tests (>2 levels).
For cohort 1 these variables were: BW, 5-min Apgar, delivery
mode (3 levels), preeclampsia, sepsis, and oxygen duration. For
cohort 2 they were: BW, 5-min Apgar, sex, brain damage, sepsis,
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amniotic infection, and oxygen duration. Due to collinearity
between BW and GA, we used only BW inMLR, where it showed
stronger correlation with NfL than GA.
RESULTS
Baseline NfL Levels
In cohort 1 overall median venous NfL concentrations were 18.2
pg/mL (IQR 12.8–30.8) at birth and 50.9 pg/mL (41.3–100.1) at
DOL 3; in cohort 2 they were 128.5 pg/mL (78.8–224.8) at DOL 7.
We split cohort 1 into a very preterm group (GA < 32 weeks;
n= 52) and amoderate preterm and term (MPT) group (GA≥32
weeks; n = 151) with fewer prematurity complications (n = 1
in our sample). This also enabled us to compare the first group
with cohort 2. NfL levels were significantly higher in very preterm
infants than in the MPT group at birth (median 32.5 pg/mL,
n = 47 vs. 15.3 pg/mL, n = 138; p < 0.001), but not at DOL 3
(median 48.5 pg/mL, n = 16 vs. 51.4 pg/mL, n = 23; p = 0.668).
Moreover, levels increased significantly from birth to DOL 3 in
both the very preterm and MPT groups (median 32.5 vs. 48.5
pg/mL, p = 0.002; and median 15.3 vs. 51.4 pg/mL, p < 0.001),
and from DOL 3 to DOL 7 in the very preterm group (median
48.5 vs. 128.5 pg/mL, p = 0.001) (Table 2). This increase was
confirmed in cohort 1 when comparing paired samples from
same infants (MPT group n = 16, very preterm group n = 11)
at birth and DOL 3 (median 18.2 pg/mL vs. 49.4 pg/mL). Out
of these, only in 2 very preterm infants NfL levels remained
unchanged, in all other infants they increased from birth until
DOL 3. Paired umbilical cord arterial and venous plasma were
closely related (R= 0.875, p< 0.001). Given this close correlation
and the greater number of subjects (n = 185), we performed
all further analyses using the venous blood samples collected at
birth.
NfL and Perinatal Characteristics in
Cohort 1
Venous cord blood at birth correlated negatively with BW
(R = −0.403, p < 0.001, Figure 1), GA (R = −0.271, p < 0.001),
5-min Apgar (R = −0.295, p < 0.001), and 10-min Apgar
(R = −0.363, p < 0.001). In contrast, levels correlated positively
with oxygen duration (R = 0.333, p < 0.001) and delivery mode
(R= 0.156, p= 0.034).
Presence of preeclampsia (31.0 pg/mL vs. 16.2, p < 0.001) and
sepsis (32.6 pg/mL vs. 17.85, p = 0.033) were associated with
higher NfL levels.
In the MPT group NfL levels at birth were significantly higher
in infants delivered vaginally than by primary or secondary
cesarean section (21.8 vs. 13.9 and 14.4 pg/mL; p = 0.002)
(Figure 2). This was not the case in the very preterm group,
presumably due to the few vaginal deliveries (n = 5 vs. n = 47
cesarean sections). At DOL 3 there was no significant difference
(p = 0.07) in NfL levels between birth modalities except for
vaginal delivery vs. cesarean section (110 pg/mL, n = 8 vs. 48.7
pg/mL, n= 31; p= 0.031).
MLR testing for the best independent predictors of NfL levels
at birth used BW, 5-min Apgar, delivery mode, preeclampsia,
sepsis and oxygen duration as explanatory variables. The model
TABLE 1 | Descriptive statistics.
Cohort 1
n = 203
Cohort 2
n = 98
Moderate Preterm
and Term (≥32
weeks GA)
n = 151
Very preterm
(< 32 weeks GA)
n = 52
Very preterm
(< 32 weeks GA)
n = 98
NEONATAL CHARACTERISTICS
GA (weeks) 38.3 (37.0–40.0) 30.1 (28.3–31.3) 29.3 (26.9–30.6)
BW (g) 3270 (2710–3630) 1360 (1063–1463) 1145 (788–1413)
Sex (male, %) 87 (57.6) 25 (48.1) 52 (53.1)
Brain damage (%) 1 (0.7) 10 (19.2) 12 (12.2)
O2 duration (days) 0 4 (1–15.8) 2.38 (0.05–22.8)
pH umbilical artery 7.30 (7.26–7.33) 7.32 (7.29–7.37) 7.32 (7.28–7.36)
NEC (%) 0 0 3 (3.1)
Sepsis (%) 0 11 (21.2) 13 (13.3)
5-min Apgar 9 (9–9) 7 (5.25–8) 7 (6–8)
Death (%) 0 6 (11.5) 2 (2.0)
MATERNAL CHARACTERISTICS
Age (years) 32 (29–36) 33 (28.3–36.0) 33 (29–36)
Amniotic infection (%) 5 (3.3) 13(25) 20 (20.4)
Preeclampsia (%) 16 (10.6) 20 (38.5) 16 (16.3)
PROM (%) 14 (9.3) 14 (26.9) 28 (28.6)
DM (%):
Primary CS 76 (50.3) 26 (50) 27 (27.6)
Secondary CS 29 (19.2) 21 (40.4) 59 (60.2)
VD 46 (30.5) 5 (9.6) 12 (12.2)
GA, gestational age; BW, birth weight; BD, brain damage (PIVH and/or PVL); NEC,
necrotizing enterocolitis; PROM, premature rupture of membranes; DM, delivery mode;
CS, cesarean section; VD, vaginal delivery. GA, BW, O2 duration, Apgar, pH and maternal
age are presented as median and interquartile range.
was significant (F(6, 176) = 8.655, p < 0.001), explaining around
23% of NfL variance (R2 = 0.228). The predictors were BW
(beta = −0.297, p = 0.003), delivery mode (beta = 0.237,
p= 0.001), and preeclampsia (beta= 0.183, p= 0.022).
NfL and Perinatal Characteristics in
Cohort 2
NfL at DOL 7 correlated negatively with the main neonatal
characteristics such as BW (R=−0.525, p< 0.001, Figure 1), GA
(R=−0.487, p < 0.001), and 5- and 10-min Apgar (R=−0.247,
p = 0.014; R = −0.228, p = 0.024). Correlation was positive
with oxygen duration (R = 0.358, p < 0.001) and maternal age
(R= 0.353, p < 0.001).
Brain damage (211.5 pg/mL vs. 123, p = 0.002) and sepsis
(184 pg/mL vs. 124.5, p= 0.020) were associated with higher NfL
levels. Delivery mode had no significant impact (p= 0.624).
MLR analysis of cohort 2 used BW, 5-min Apgar, sex, brain
damage, sepsis, amniotic infection, and oxygen duration as
explanatory variables. The regression model explained around
37% of NfL variance (R2 = 0.366, F(7, 89) = 7.331, p < 0.001).
Only BW (beta = −0.385, p = 0.001) and brain damage
(beta = 0.222, p = 0.015) contributed significantly to predicting
NfL (Figure 2).
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DISCUSSION
Neuronal injury marker NfL has proved a sensitive and specific
biomarker in adult peripheral blood, serving as a promising
adjunct to monitoring and decision-making in acute and chronic
neurologic disease (16, 17). Our study provides a first insight
into neonatal NfL levels in term and preterm infants. The major
findings are that NfL levels increase over the first few days of
life, relate inversely to prematurity and BW, and identify BW,
delivery mode, preeclampsia and brain damage as independent
predictors.
NfL levels at birth in MPT infants resemble those in healthy
adults (15). By DOL 3 they rise to the levels seen in adults
with neurodegenerative disease such as multiple sclerosis (15).
At DOL 7 in very preterm infants NfL levels are in the range of
asphyxiated neonates at DOL 4 (11).
The main influencers of NfL in both cohorts were BW and
maturity: birth and neonatal levels were both higher in low
BW infants (Figure 1), perhaps because brain vulnerability to
neuronal injury increases with prematurity. Alternatively, high
NfL levels in preterm infants might be due to high neuronal
TABLE 2 | Cohort neurofilament light chain concentrations at birth and at days of
life (DOL) 3 and 7.
Cohort Neurofilament light chain concentrations (pg/mL)
Birth
(arterial)
Birth
(venous)
DOL 3
(venous)
DOL 7
(venous)
1: Very preterm group
(GA < 32 weeks)
n = 52
32.5
(17.6–52.5)
n = 47
48.5
(37.6–138)
n = 16
1: Moderate Preterm
and Term group
(GA ≥32 weeks)
n = 151
17.7
(12.4–25.4)
n = 68
15.3
(12.2–23.9)
n = 138
51.4
(41.4–86.4)
n = 23
2: Very preterm group
(GA < 32 weeks)
n = 98
126
(78.8–225)
n = 98
Median and interquartile range. GA, gestational age.
turnover in general, with the much higher postnatal levels at
DOL 3 and DOL 7 (Figure 2) simply reflecting a neuronal stress
reaction to birth, as in healthy term neonates.
Preterm infants are at risk for perinatal brain damage, in
particular PIVH and PVL (18). In our sample those with evidence
of brain damage had significantly higher NfL levels than those
without (Figure 2). Brain damage leads directly to neuronal
injury, to a degree objectifiable by NfL: levels are higher in
asphyxiated neonates with unfavorable brain MRI outcome (11).
As in adults, cerebrovascular accident results in immediately
higher NfL levels (19), compared to the more gradual neuronal
damage seen in neurodegenerative disease (20).
In addition to a direct effect of brain damage, we identified
two other stressors that increase NfL, namely delivery mode and
preeclampsia. Levels were higher in infants delivered vaginally
than by cesarean section (Figure 2), suggesting greater neuronal
injury and confirming vaginal delivery as one of life’s strongest
stressors, causing incommensurable release of various fetal stress
hormones (21). Preeclampsia, a pregnancy-specific syndrome
defined by high blood pressure and other morbidities (22),
was the additional stressor, raising NfL levels at birth even
after adjustment for BW and GA. Our finding is consistent
with the recent report of raised NfL levels in women with
preeclampsia (23). Maternal hypertension is closely linked to
placental insufficiency which compromises fetal perfusion and
may cause cardiovascular disease later in life (24). Our data
indicate that preeclampsia involves a risk of neuronal damage in
the unborn child.
While the main source of NfL is considered to be the
central nervous system, peripheral damage may contribute to
increased NfL values as well, as recently revealed by studies on
peripheral neuropathies (25, 26). Increased blood levels of the
muscle enzyme creatine kinase in newborn infants after vaginal
deliveries compared to cesarean sections have been reported
(27). They support the notion that increased NfL in these
babies may result, at least in part, from peripheral neuronal
damage. However, data on the central nervous system biomarker
S100 B measured in the maternal serum and cord blood show
clearly increased S100B values after vaginal delivery compared
to cesarean section (28). It has been shown previously that
FIGURE 1 | Correlation between birth weight and NfL. (A) Birth (cohort 1). (B) DOL 7 (cohort 2).
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FIGURE 2 | Effect of delivery mode and brain damage on NfL. (A) NfL at birth in infants with GA ≥ 32 weeks (cohort 1). (B) NfL at DOL 7 (cohort 2). Absent, no brain
damage; present, PIVH and/or PVL. Boxplots are presented with median and IQR. The * are extreme outliers.
extracranial sources of S100B do not affect serum levels (29).
Taken together, the findings of Schulpis KH et al. corroborate our
data that increased levels of the neuronal injury markers S100B
and NfL might be caused by the compression on the fetus’ brain
during delivery.
Further, S100B levels in neonates with HIE exceeded those in
healthy controls, proportionately to disease severity and worse
outcome (30). Although S100B levels decreased overall from
DOL 1 through DOL 9 (31), levels in preterm and term neonatal
saliva followed a pattern similar to NfL, being higher in preterm
than in term infants and correlating negatively with GA (32).
Nerve growth factor (NGF) is a neurotrophic factor involved in
brain development and neuroplasticity following brain damage.
Unlike NfL, NGF levels in maternal and cord plasma are lower in
preterm than in term deliveries (33).
To date the metabolism of NfL in cerebrospinal fluid (CSF)
and blood is largely unknown, ways of elimination or protein
degradation have not been described. One study examined the
influence of blood brain barrier permeability and blood NfL
levels. In this study there was no correlation between serum NfL
concentration and CSF/serum albumin ratio (34).
Study limitations include the relatively few subjects sampled
at DOL 3, which may account for the non-significant difference
between very preterm and MPT infants at DOL 3. In the
first week of life there is an apparent increase in NfL levels,
but in the absence of data points post-DOL 7, the subsequent
profile of NfL requires elucidation in further studies. Nor can
we exclude other confounders that might influence and explain
NfL. Cognitive outcome studies will need to confirm the use
of NfL as a predictive biomarker of brain damage and eventual
neurodevelopmental deficit. Such early biomarkers are sorely
needed to complement ultrasound or MRI in conditions such
as PVL (18). In addition, future studies may explore NfL
together with other potentially promising biomarkers of brain
damage (35). More generally, research is required to explore and
disentangle the causes of the high degree of neuronal injury in the
preterm brain.
CONCLUSION
This study provides an initial insight into neuronal injury marker
NfL in term and preterm infants. Levels increase through the first
week of life. They relate inversely to GA and BW and are higher
in brain injury. Obstetric parameters such as delivery mode and
preeclampsia also raise NfL levels. Our study supports the use
of NfL in neonates to help us understand the factors leading
to neuroaxonal injury and how we might monitor and prevent
them.
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III. DISCUSSION 
The aim of the present PhD thesis is to explore neuronal biomarkers as tool for 
detection of preterm infants at higher risk for neurodevelopmental delays. First, 
through a systematic review of the literature we examined previous studies that 
assessed the association between AERPs and cognitive outcome in preterm infants. 
Second, we performed a prospective pilot study to assess discrimination and 
habituation in preterm and term infants using AERPs and to correlate the habituation 
capability with the developmental outcome. Third, a blood biomarker of neuronal 
injury was investigated in a cohort of term and preterm infants during the first week of 
life. Given the potential of this biomarker in adults, we want to see whether it is 
possible to measure it and utilize in a preterm population.  
These three studies provide a brief overview of the current state of AERP research in 
the field of neuropediatrics together with an investigation of two neuronal biomarkers.  
3.1. Predicting neurodevelopmental outcome in preterm infants  
The first two publications focus on EEG methodology, in particular AERPs, used in 
preterm infants to investigate whether defined AERP peaks can be used as a marker 
for cognitive functioning.   
After systematically reviewing the literature, it appeared that only few studies 
(Fellman et al., 2004; Hovel et al., 2015; Jansson-Verkasalo et al., 2003; Jansson-
Verkasalo et al., 2004; Jansson-Verkasalo et al., 2010; Korpilahti et al., 2016; 
Leipala, Partanen, Kushnerenko, Huotilainen, & Fellman, 2011; Maitre, Lambert, 
Aschner, & Key, 2013; Maitre, Slaughter, Aschner, & Key, 2014; Mikkola et al., 2007; 
Mikkola et al., 2010; Paquette et al., 2015; Weber, Depoorter, Hetzel, & Lemola, 
2016) have examined the association between AERPs and cognitive outcome. In 
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particular 13 studies, of which seven prospective and six cross-sectional, have been 
found and included in the systematic review. Five long latency AERPs, P1, N2, P3, 
MMN and N400 were examined in the studies and mismatch negativity (MMN) was 
the most commonly investigated component. According to six studies MMN was 
predictive of cognitive outcome. The majority of the included studies found significant 
correlations between the AERPs and outcome tests. In summary, shorter latencies 
and larger amplitudes of long latency AERPs were related to better cognitive 
outcome. However it is challenging to create guidelines (Tome, Barbosa, Nowak, & 
Marques-Teixeira, 2015) based on this review due to the heterogeneity of 
participants (regarding gestational age and brain injury), variety of stimulation 
paradigms and investigated peaks. Two studies (Maitre et al., 2013; Maitre et al., 
2014) did not define specific late AERP peaks, but specified time windows of interest. 
Given the challenges associated with detecting typical potentials in neonates, in 
contrast to older children and adults, this is reasonable. The variability in AERPs in 
very young children can be explained by the immaturity of auditory processing 
(Ceponiene et al., 2002; Kushnerenko et al., 2002; Leppanen et al., 2004), hence GA 
has a big influence on the apparition of peaks (Bisiacchi, Mento, & Suppiej, 2009). 
This is to our knowledge the first review to systematically study the potential of 
AERPs to predict neurodevelopmental outcome. This review demonstrates that more 
research is needed on neonatal AERPs, in order to apply this method in a clinical 
setting. It is important that studies use a similar setting, paradigm and time of 
assessment to increase comparability among study sites.  
In the second manuscript, a closer look is taken at the predictive capacities of the 
MMN at neonatal age in healthy preterm and term born infants. MMN is an AERP 
component commonly investigated in ERP research in the auditory modality 
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(Naatanen, Paavilainen, Rinne, & Alho, 2007). MMN is elicited in an oddball 
paradigm and calculated by subtracting the average waveform of the standard stimuli 
from the average waveform of the deviant stimuli. In adults it displays a negative 
amplitude peaking between 100 and 250 ms post stimulus onset (Naatanen et al., 
2007). MMN reflects a preattentive cognitive discrimination ability and can be 
observed in neonates (Ceponiene et al., 2002; Haden, Nemeth, Torok, & Winkler, 
2016). From previous studies its potential role as predictor of early language 
development has been shown (Mikkola et al., 2007; Paquette et al., 2015). In the 
second manuscript we took a closer look at the properties of MMN, not yet assessed 
by other AERP studies. In particular habituation, an elementary form of learning, can 
provide an indication of cognitive development in young infants (Kavsek & Bornstein, 
2010). We found that a diminished habituation capability is associated with a lower 
mental and psychomotor outcome at the corrected age of 21 months in very preterm 
infants. This is in line with the findings of Kavsek et al. from behavioral studies 
(Kavsek & Bornstein, 2010). Moreover the habituation capability strongly correlated 
with GA, as previously confirmed by Morokuma’s fMRI study (Morokuma et al., 
2004). In our study we did not find significant differences in MMN amplitude or 
latency between preterm and term infants at 40 weeks GA, although preterm infants 
showed considerably lower amplitudes (<2 µV). The absence of group differences in 
MMN is in accordance with other studies using speech (Rago, Honbolygo, Rona, 
Beke, & Csepe, 2014) and non-speech stimuli (Paquette et al., 2015). The finding 
that proportionally more preterm infants showed lower amplitudes than their peers, is 
understood as diminished preattentive sound discrimination and consequently a sign 
of immaturity of the auditory system (Ceponiene et al., 2002). It is important to note 
that the very preterm infants included in this study did not have any severe brain 
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malformations or damage, therefore the results are supposed to be solely concerning 
the “preterm brain”.  
Taken together, AERP studies provide evidence to use this particular EEG task for 
investigating early cognitive functioning in neonates. It is a bedside tool that has the 
potential to individually stratify preterm infants at risk during hospitalization at the 
NICU. Additionally it is non-invasive, inexpensive and can be passively administered. 
3.2. Blood biomarker of neonatal neuronal injury  
Similar to neuroimaging studies, blood biomarkers have been looked into and 
explored in order to develop techniques to screen for brain injuries and functioning. 
Neuronal biomarkers have been comprehensively studied in adults, but to a lesser 
extent in neonates. Nevertheless, several neuronal biomarkers have been 
discovered useful. Blood biomarkers such as S100B and Activin were found suitable 
to predict occurrence of IVH (Douglas-Escobar & Weiss, 2012; Michetti et al., 2012). 
Data on prediction of outcome in infants using neuronal biomarkers are currently 
missing (Daoud et al., 2014). In the third manuscript we took a closer look at a novel 
biomarker with high potential that was investigated for the very first time in preterm 
and term born infants.  
The main findings were that NfL at birth was increased in very preterm compared to 
moderate preterm-term infants and increased over the first days of life. Clinical 
factors that influenced NfL in both groups were GA, BW, Apgar scores, duration of 
oxygen supply and presence of sepsis. So in general the “sicker” the infant, the 
higher the NfL levels and therefore potentially higher neuroaxonal injury. Exclusively 
in very preterm infants brain damage was an independent predictor of NfL, besides 
BW or GA. Whereas in the cohort of moderate preterm and term infant obstetric 
parameters, such as delivery modality and preeclampsia in the mother, as well as 
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BW or GA had the highest impact on NfL. In particular infants delivered vaginally 
presented increased levels compared to those delivered by cesarean section. This 
finding supports vaginal delivery as a stressor for infants and is in accordance with 
the S100B biomarker (Schulpis et al., 2006). Other neuronal biomarkers such as 
brain-derived neurotrophic factor (Flock et al., 2016) and nerve growth factor 
(Dhobale, Mehendale, Pisal, Nimbargi, & Joshi, 2012), linked to immaturity of the 
central nervous system, are reduced in the cord blood of preterm infants and 
corroborate our findings that GA/BW is the main influencer of increased neuronal 
injury. In this study it is important to underline that in the preterm cohort there are 
some infants that have brain injury, but only few with IVH Grade 3-4. 
Based on what we know from the adult literature and the few promising studies in 
infants (Shah et al., 2018; Toorell et al., 2018), we expect that NfL can also act as a 
predictor of later cognitive functioning.  
3.3. Limitations and outlook 
After providing a brief overview and discussing the three PhD publications, some 
limitations of the studies need to be addressed as well as suggestions for future 
studies investigating neuronal biomarkers in the neonatal population. First of all the 
small sample size in the EEG studies is a big weakness in order to generalize 
findings to the preterm population, as well as the accompanying low statistical power 
and the few electrode positions in most cases. High dropout rates in longitudinal 
studies are also a concern for outcome predictions. Due to the ongoing brain 
development and immaturity it is also difficult to validate AERPs in neonates. In EEG 
research there is a high variety in paradigms, electrodes and outcome tests which 
also makes it difficult to compare studies. To improve this, multicenter studies using 
identical study protocols should be encouraged. The same holds for research on 
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body fluid biomarkers where many different immunoassay methods exist. 
Consequently there is a need for standard protocols and guidelines in order to 
translate findings from research to clinical practice (Berger et al., 2012). One of the 
benefits of studies investigating blood biomarkers in neonates is that it is less 
complicated to obtain big cohorts and to create norms as compared to neuroimaging. 
In order to validate a biomarker it is important to have distinct groups, such as 
“healthy” preterm (as included in the second publication) versus “sick” preterm (with 
morbidities) and healthy term infants as well as groups based on GA (extreme, very, 
moderate preterm). In case of documented brain injuries (i.e. IVH or PVL) it is 
important to control for, in order to clearly investigate the “premature brain”. The next 
important steps for Nf as a marker of neuronal injury in preterm infants are to 
correlate it with CUS, MRI and EEG findings plus to link it to neurodevelopmental 
outcome tests.    
3.4. Conclusion  
Preterm birth is associated with a range of morbidities and neurodevelopmental 
deficits. This poses a serious concern for clinicians worldwide, especially given the 
increasing rate of preterm births. While not all preterm infants develop later cognitive 
deficits, a screening tool to detect those at higher risk is required. Based on the 
present work we can propose a complementary use of the investigated neuronal 
biomarkers, AERPs and Nf, to assess cognitive development. For instance in case of 
elevated Nf levels, an AERP test can be performed in order to investigate early 
cognitive functioning. However more high quality studies with similar, large cohorts 
are needed before guidelines can be elaborated.  
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